Hubbry Logo
CigaretteCigaretteMain
Open search
Cigarette
Community hub
Cigarette
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Cigarette
Cigarette
from Wikipedia

A filtered cigarette

A cigarette is a thin cylinder of tobacco rolled in thin paper for smoking. The cigarette is ignited at one end, causing it to smolder, and the resulting smoke is orally inhaled via the opposite end. Cigarette smoking is the most common method of tobacco consumption. The term cigarette, refers to a tobacco cigarette, but the word is sometimes used to refer to other substances, such as a cannabis cigarette or a herbal cigarette. A cigarette is distinguished from a cigar by its usually smaller size, use of processed leaf, different smoking method, and paper wrapping, which is typically white.

There are significant negative health effects from smoking cigarettes such as cancer, chronic obstructive pulmonary disease (COPD), heart disease, birth defects, and other health problems relating to nearly every organ of the body. Most modern cigarettes are filtered, however this does not make the smoke inhaled from them contain fewer carcinogens or harmful chemicals. Nicotine, the psychoactive drug in tobacco, makes cigarettes highly addictive. About half of cigarette smokers die of tobacco-related disease and lose on average 14 years of life. Every year, cigarette smoking causes more than 8 million deaths worldwide; more than 1.3 million of these are non-smokers dying as the result of exposure to secondhand smoke.[1] These harmful effects have led to legislation that has prohibited smoking in many workplaces and public areas, regulated marketing and purchasing age of tobacco, and levied taxes to discourage cigarette use.

An electronic cigarette

In the 21st century electronic cigarettes (also called e-cigarettes or vapes) were developed, whereby a substance contained within (typically a liquid solution containing nicotine) is vaporized by a battery-powered heating element as opposed to being burned. Such devices are commonly promoted by their manufacturers as safer alternatives to conventional cigarettes. Since e-cigarettes are a relatively new product, scientists do not have data on their possible long-term health effects, but there are significant health risks associated with their use.

History

[edit]

Global

[edit]
A reproduction of a carving from the temple at Palenque, Mexico, depicting a Maya deity using a smoking tube

The earliest forms of cigarettes were similar to their predecessor, the cigar. Cigarettes appear to have had antecedents in Mexico and Central America around the 9th century in the form of reeds and smoking tubes. The Maya, and later the Aztecs, smoked tobacco and other psychoactive drugs in religious rituals and frequently depicted priests and deities smoking on pottery and temple engravings. The cigarette and the cigar were the most common methods of smoking in the Caribbean, Mexico, and Central and South America until recent times.[2]

The North American, Central American, and South American cigarette used various plant wrappers; when it was brought back to Spain, maize wrappers were introduced, and by the 17th century, fine paper. The resulting product was called papelate and is documented in Goya's paintings La Cometa, La Merienda en el Manzanares, and El juego de la pelota a pala (18th century).[3]

By 1830 the cigarette had become known in France, where it received the name cigarette, and in 1845 the French state tobacco monopoly began manufacturing them.[3] The French word made its way into English in the 1840s.[4] Some American reformers promoted the spelling cigaret,[5][6] but this was never widespread and is now largely abandoned.[7]

The first patented cigarette-making machine was invented by Juan Nepomuceno Adorno of Mexico in 1847.[8] In the 1850s, Turkish cigarette leaves had become popular.[9] However, production climbed markedly when another cigarette-making machine was developed in the 1880s by James Albert Bonsack, which vastly increased the productivity of cigarette companies, which went from making about 40,000 hand-rolled cigarettes daily to around 4 million.[10] At the time, these imported cigarettes from the United States had significant sales among British smokers.[9]

In the English-speaking world, the use of tobacco in cigarette form became increasingly widespread during and after the Crimean War, when British soldiers began emulating their Ottoman Turkish comrades and Russian enemies, who had begun rolling and smoking tobacco in strips of old newspaper for lack of proper cigar-rolling leaf.[3] This was helped by the development of tobaccos suitable for cigarette use, and by the development of the Egyptian cigarette export industry.

Francisco Goya's La Cometa, depicting a (foreground left) man smoking an early quasicigarette

Initially, not all cigarette smokers inhale the smoke produced by cigarette due to the high alkalinity levels. Starting in the 1930s, an advertising campaign was done by the tobacco industry to encourage inhaling.[11] However, Helmuth von Moltke noticed in the 1830s that Ottomans (and he himself) inhaled the Turkish tobacco and Latakia from their pipes[12] (which are both initially sun-cured, acidic leaf varieties).

A 1942 ad encourages women to smoke Camel brand cigarettes.

The widespread smoking of cigarettes in the Western world is largely a 20th-century phenomenon. By the late 19th century cigarettes were known as coffin nails[13] but the link between lung cancer and smoking was not established until the 20th century.[14] German doctors were the first to make the link, and it led to the first antitobacco movement in Nazi Germany.[15][16][17]

Cigarette brands, including Craven "A", advertised in Shaftesbury Avenue, London in 1949

During World War I and World War II, cigarettes were rationed to soldiers. During the Vietnam War, cigarettes were included with C-ration meals. In 1975, the U.S. government stopped putting cigarettes in military rations. During the second half of the 20th century, the adverse health effects of tobacco smoking started to become widely known and printed health warnings became common on cigarette packets.

Graphical cigarette warning labels are a more effective method to communicate to the public the dangers of cigarette smoking.[18] Canada, Mexico, Belgium, Denmark, Sweden, Thailand, Malaysia, India, Pakistan, Australia, Argentina, Brazil, Chile, Peru,[19] Greece, the Netherlands,[20] New Zealand, Norway, Hungary, the United Kingdom, France, Romania, Singapore, Egypt, Jordan, Nepal and Turkey all have both textual warnings and graphic visual images displaying, among other things, the damaging effects tobacco use has on the human body. The United States has implemented textual but not graphical warnings.

The cigarette has evolved much since its conception; for example, the thin bands that travel transverse to the "axis of smoking" (thus forming circles along the length of the cigarette) are alternate sections of thin and thick paper to facilitate effective burning when being drawn, and retard burning when at rest. Synthetic particulate filters may remove some of the tar before it reaches the smoker.

The "holy grail" for cigarette companies has been a cancer-free cigarette. On record, the closest historical attempt was produced by scientist James Mold. Under the name project TAME, he produced the XA cigarette. However, in 1978, his project was terminated.[21][22][23]

Since 1950, the average nicotine and tar content of cigarettes has steadily fallen. Research has shown that the fall in overall nicotine content has led to smokers inhaling larger volumes per puff.[24]

United States

[edit]

One entrepreneur who was quick to spot the advantages of machine-made cigarettes was James Buchanan Duke. Previously a producer of smoking tobacco only, his firm, W. Duke & Sons & Co., entered the cigarette industry in the early 1880s. After installing two Bonsack machines, Duke spent heavily on advertising and sales promotion with the result that by 1889 his was the largest cigarette manufacturer in the country. The new Bonsack machines were of decisive importance in rapid, cheap manufacture of all tobacco products but one. Cigars needed slow, laborious hand rolling and were produced in hundreds of small workshops, especially in New York City. In 1890 Duke and the other four major cigarette companies combined to form the American Tobacco Company, a firm that dominated the market and used aggressive tactics on hundreds of small competitors until they sold out. It was called the "Tobacco Trust." The trust soon expanded its operations to include cigars, smoking, chewing tobacco and snuff. Among the companies drawn into this organization were plug manufacturers, Liggett & Myers and R. J. Reynolds Tobacco Company, which at the time produced twist and flat plug, and P. Lorillard, an old-line manufacturer of snuff. By 1910 the trust produced 86% of all cigarettes produced in the United States, and 75% to 95% of other forms, but only 14% of the cigars.[25]

At the start of the 20th century, the per capita annual consumption in the U.S. was 54 cigarettes (with fewer than 0.5% of the population smoking more than 100 cigarettes per year), and consumption there peaked at 4,259 per capita in 1965. At that time, about 50% of men and 33% of women smoked (defined as smoking more than 100 cigarettes per year).[26] By 2000, consumption had fallen to 2,092 per capita, corresponding to about 30% of men and 22% of women smoking more than 100 cigarettes per year, and by 2006 per capita consumption had declined to 1,691;[27] implying that about 21% of the population smoked 100 cigarettes or more per year.

Construction

[edit]
Diagram of a cigarette
  1. Mainstream smoke
  2. Filtration material
  3. Adhesives
  4. Ventilation holes
  5. Ink
  6. Adhesive
  7. Sidestream smoke
  8. Filter
  9. Tipping Paper
  10. Tobacco and ingredients
  11. Paper
  12. Burning point and ashes

Manufacturers have described the cigarette as "a drug administration system for the delivery of nicotine in acceptable and attractive form".[28][29][30][31] Modern commercially manufactured cigarettes are seemingly simple objects consisting mainly of a tobacco blend, paper, PVA glue to bond the outer layer of paper together, and often also a cellulose acetate–based filter.[32] While the assembly of cigarettes is straightforward, much focus is given to the creation of each of the components, in particular the tobacco blend. A key ingredient that makes cigarettes more addictive is the inclusion of reconstituted tobacco, which has additives to make nicotine more volatile as the cigarette burns.[33]

Paper

[edit]

The paper for holding the tobacco blend may vary in porosity to allow ventilation of the burning ember or contain materials that control the burning rate of the cigarette and stability of the produced ash. The papers used in tipping the cigarette (forming the mouthpiece) and surrounding the filter stabilize the mouthpiece from saliva and moderate the burning of the cigarette, as well as the delivery of smoke with the presence of one or two rows of small laser-drilled air holes.[34]

Tobacco blend

[edit]
Leones Africanos brand cigarettes from the mid-20th century, part of the permanent collection of the Museo del Objeto del Objeto

The process of blending gives the end product a consistent taste from batches of tobacco grown in different areas of a country that may change in flavor profile from year to year due to different environmental conditions.[35]

Modern cigarettes produced after the 1950s, although composed mainly of shredded tobacco leaf, use a significant quantity of tobacco processing byproducts in the blend. Each cigarette's tobacco blend is made mainly from the leaves of flue-cured brightleaf, burley tobacco, and oriental tobacco. These leaves are selected, processed, and aged prior to blending and filling. The processing of brightleaf and burley tobaccos for tobacco leaf "strips" produces several byproducts such as leaf stems, tobacco dust, and tobacco leaf pieces ("small laminate").[35] To improve the economics of producing cigarettes, these byproducts are processed separately into forms where they can then be added back into the cigarette blend without an apparent or marked change in the cigarette's quality. The most common tobacco byproducts include:

  • Blended leaf (BL) sheet: a thin, dry sheet cast from a paste made with tobacco dust collected from tobacco stemming, finely milled burley-leaf stem, and pectin.[36]
  • Reconstituted leaf (RL) sheet: a paper-like material made from recycled tobacco fines, tobacco stems and "class tobacco", which consists of tobacco particles less than 30 mesh in size (about 0.6 mm) that are collected at any stage of tobacco processing:[37] RL is made by extracting the soluble chemicals in the tobacco byproducts, processing the leftover tobacco fibers from the extraction into a paper, and then reapplying the extracted materials in concentrated form onto the paper in a fashion similar to what is done in paper sizing. At this stage, ammonium additives are applied to make reconstituted tobacco an effective nicotine delivery system.[33]
  • Expanded (ES) or improved stem (IS): ES is rolled, flattened, and shredded leaf stems that are expanded by being soaked in water and rapidly heated. Improved stem follows the same process, but is simply steamed after shredding. Both products are then dried. These products look similar in appearance, but are different in taste.[35]

According to data from the World Health Organization,[38] the amount of tobacco per 1000 cigarettes fell from 1.03 kg (2.28 pounds) in 1960 to 0.41 kg (0.91 pounds) in 1999, largely as a result of reconstituting tobacco, fluffing, and additives.

A recipe-specified combination of brightleaf, burley-leaf, and oriental-leaf tobacco is mixed with various additives to improve its flavors. Most commercially available cigarettes today contain tobacco that is treated with sugar to counter the harshness of the smoke.

Additives

[edit]

Various additives are combined into the shredded tobacco product mixtures, with humectants such as propylene glycol or glycerol, as well as flavoring products and enhancers such as cocoa solids, licorice, tobacco extracts, and various sugars, which are known collectively as "casings".[39] The leaf tobacco is then shredded, along with a specified amount of small laminate, expanded tobacco, BL, RL, ES, and IS. A perfume-like flavor/fragrance, called the "topping" or "toppings", which is most often formulated by flavor companies, is then blended into the tobacco mixture to improve the consistency in flavor and taste of the cigarettes associated with a certain brand name.[35] Additionally, they replace lost flavors due to the repeated wetting and drying used in processing the tobacco. Finally, the tobacco mixture is filled into cigarette tubes and packaged.

A list of 599 cigarette additives, created by five major American cigarette companies, was approved by the Department of Health and Human Services in April 1994. None of these additives is listed as an ingredient on the cigarette packs. Chemicals are added for organoleptic purposes and many boost the addictive properties of cigarettes, especially when burned.[40]

One of the classes of chemicals on the list, ammonia salts, convert bound nicotine molecules in tobacco smoke into free nicotine molecules.[39] This process, known as freebasing, could potentially increase the effect of nicotine on the smoker, but experimental data suggests that absorption is, in practice, unaffected.[41]

Cigarette tube

[edit]

Cigarette tubes are prerolled cigarette paper usually with an acetate or paper filter at the end. They have an appearance similar to a finished cigarette, but are without any tobacco or smoking material inside. The length varies from Regular (70 mm) to King Size (84 mm) as well as 100s (100 mm) and 120s (120 mm).[42][self-published source?]

Filling a cigarette tube is usually done with a cigarette injector (also known as a shooter). Cone-shaped cigarette tubes, known as cones, can be filled using a packing stick or straw because of their shape. Cone smoking is popular because as the cigarette burns, it tends to get stronger and stronger. A cone allows more tobacco to be burned at the beginning than the end, allowing for an even flavor[43]

The United States Tobacco Taxation Bureau defines a cigarette tube as "Cigarette paper made into a hollow cylinder for use in making cigarettes."[44]

Cigarette filter

[edit]

A cigarette filter or filter tip is a component of a cigarette. Filters are typically made from cellulose acetate fibre. Most factory-made cigarettes are equipped with a filter; those who roll their own can buy them separately. Filters can reduce some substances from smoke but do not make cigarettes any safer to smoke.

Cigarette butt

[edit]
Discarded cigarette butts

In North America, the common name for the remains of a cigarette after smoking is a cigarette butt. In Britain, it is also called a dog-end.[45] The butt is typically about 30% of the cigarette's original length. It consists of a tissue tube which holds a filter and some remains of tobacco mixed with ash.

They are the most numerically frequent litter in the world.[46] Cigarette butts accumulate outside buildings, on parking lots, and streets where they can be transported through storm drains to streams, rivers, and beaches.[47] In a 2013 trial, the city of Vancouver, British Columbia, partnered with TerraCycle to create a system for recycling of cigarette butts. A reward of 1¢ per collected butt was offered to determine the effectiveness of a deposit system similar to that of beverage containers.[48][49]

Electronic cigarette

[edit]
Various types of electronic cigarettes.
Various types of electronic cigarettes

An electronic cigarette (commonly known as a vape) is a handheld battery-powered vaporizer that simulates smoking by providing some of the behavioral aspects of smoking, including the hand-to-mouth action of smoking, but without combusting tobacco.[50] Using an e-cigarette is known as "vaping" and the user is referred to as a "vaper".[51] Instead of cigarette smoke, the user inhales an aerosol, commonly called vapor.[52] E-cigarettes typically have a heating element that atomizes a liquid solution called e-liquid.[53] E-cigarettes are automatically activated by taking a puff;[54] others turn on manually by pressing a button.[51] Some e-cigarettes look like traditional cigarettes,[55] but they come in many variations.[51] Most versions are reusable, though some are disposable.[56] There are first-generation,[57] second-generation,[58] third-generation,[59] and fourth-generation devices.[60] E-liquids usually contain propylene glycol, glycerin, nicotine, flavorings, additives, and differing amounts of contaminants.[61] E-liquids are also sold without propylene glycol,[62] nicotine,[63] or flavors.[64]

The benefits and the health risks of e-cigarettes are uncertain.[65][66][67] There is moderate-certainty evidence that e-cigarettes with nicotine may help people quit smoking when compared with e-cigarettes without nicotine and nicotine replacement therapy.[68] However, other studies have not supported the finding that e-cigarettes are proven to be more effective than smoking cessation medicine.[69] There is concern with the possibility that non-smokers and children may start nicotine use with e-cigarettes at a rate higher than anticipated than if they were never created.[70] Following the possibility of nicotine addiction from e-cigarette use, there is concern children may start smoking cigarettes.[70] Youth who use e-cigarettes are more likely to go on to smoke cigarettes.[71][72] Their part in tobacco harm reduction is unclear,[73] while another review found they appear to have the potential to lower tobacco-related death and disease.[74] Regulated US Food and Drug Administration nicotine replacement products may be safer than e-cigarettes,[73] but e-cigarettes are generally seen as safer than combusted tobacco products.[75][76] It is estimated their safety risk to users is similar to that of smokeless tobacco.[77] The long-term effects of e-cigarette use are unknown.[68][78][79] The risk from serious adverse events was reported in 2016 to be low.[80] Less serious adverse effects include abdominal pain, headache, blurry vision,[81] throat and mouth irritation, vomiting, nausea, and coughing.[82] Nicotine itself is associated with some health harms.[83] In 2019 and 2020, an outbreak of severe lung illness throughout the US was linked to the use of vaping products[84]

E-cigarettes create vapor made of fine and ultrafine particles of particulate matter,[82] which have been found to contain propylene glycol, glycerin, nicotine, flavors, small amounts of toxicants,[82] carcinogens,[85] and heavy metals, as well as metal nanoparticles, and other substances.[82] Its exact composition varies across and within manufacturers, and depends on the contents of the liquid, the physical and electrical design of the device, and user behavior, among other factors.[52] E-cigarette vapor potentially contains harmful chemicals not found in tobacco smoke.[86] E-cigarette vapor contains fewer toxic chemicals,[82] and lower concentrations of potential toxic chemicals than cigarette smoke.[87] The vapor is probably much less harmful to users and bystanders than cigarette smoke,[85] although concern exists that the exhaled vapor may be inhaled by non-users, particularly indoors.[88]

Health effects

[edit]

Smokers

[edit]
Artistas brand cigarette package of Mexico from the Museo del Objeto del Objeto collection
A 2024 study estimated that each cigarette reduces life expectancy by 20 minutes

The harm from smoking comes from the many toxic chemicals in the natural tobacco leaf and those formed in smoke from burning tobacco.[89] A 2024 study estimated that each cigarette reduces life expectancy by 20 minutes.[90][91] Humans continue to smoke because nicotine, the primary psychoactive chemical in cigarettes, is highly addictive.[92] Cigarettes, like narcotics, have been described as "strategically addictive", with the addictive properties being a core component of the business strategy.[93] About half of smokers die from a smoking-related cause.[1][94][95] Smoking harms nearly every organ of the body. Smoking leads most commonly to diseases affecting the heart,[96] liver, and lungs, being a major risk factor for heart attacks, strokes, chronic obstructive pulmonary disease (COPD) (including emphysema and chronic bronchitis), and cancer[96][97][98][99][100] (particularly lung cancer, cancers of the larynx and mouth, and pancreatic cancer). It also causes peripheral vascular disease and hypertension. The incidence of erectile dysfunction is approximately 85 percent higher in men who smoke compared to men who do not smoke.[101][102] Children born to women who smoke during pregnancy are at higher risk of congenital disorders, cancer, respiratory disease, and sudden death.[103] On average, each cigarette smoked is estimated to shorten life by 11 minutes.[95][104][105] Starting smoking earlier in life and smoking cigarettes higher in tar increases the risk of these diseases. The World Health Organization estimates that tobacco causes 8 million deaths each year as of 2019[1] and 100 million deaths over the course of the 20th century.[106] Cigarettes produce an aerosol containing over 4,000 chemical compounds, including nicotine, carbon monoxide, acrolein, and oxidant substances.[103][107] Over 70 of these are carcinogens.[108]

The most important chemical compounds causing cancer are those that produce DNA damage since such damage appears to be the primary underlying cause of cancer.[109] Cigarette smoking results in oxidative stress and oxidative DNA damage. DNA damage can be estimated by measuring urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) and 8-oxoguanine DNA glycosylase (OGG1).[110] DNA damage was found in a population study to be significantly increased in 250 cigarette smokers compared to 200 non-cigarette smokers.[110] Cunningham et al.[111] combined the microgram weight of the compound in the smoke of one cigarette with the known genotoxic effect per microgram to identify the most carcinogenic compounds in cigarette smoke. The seven most important carcinogens in tobacco smoke are shown in the table, along with DNA alterations they cause.

The most genotoxic cancer causing chemicals in cigarette smoke
Compound Micrograms per cigarette Effect on DNA Ref.
Acrolein 122.4 Reacts with deoxyguanine and forms DNA crosslinks, DNA-protein crosslinks and DNA adducts [112]
Formaldehyde 60.5 DNA-protein crosslinks causing chromosome deletions and re-arrangements [113]
Acrylonitrile 29.3 Oxidative stress causing increased 8-oxo-2'-deoxyguanosine [114]
1,3-butadiene 105.0 Global loss of DNA methylation (an epigenetic effect) as well as DNA adducts [115]
Acetaldehyde 1448.0 Reacts with deoxyguanine to form DNA adducts [116]
Ethylene oxide 7.0 Hydroxyethyl DNA adducts with adenine and guanine [117]
Isoprene 952.0 Single and double strand breaks in DNA [118]
Number of Current and Expected Smokers, and Expected Deaths[119]
Country Current and future smokers,

ages 15+ (millions)

Approximate number of deaths in current

and future smokers younger than 35, unless they quit (millions)

China (2010) 193 97
Indonesia (2011) 58 29
Russian Federation

(2008)

32 16
United States (2011) 26 13
India (2009) 95 48
Bangladesh (2009) 25 13

"Ulcerative colitis is a condition of nonsmokers in which nicotine is of therapeutic benefit."[120] A recent review of the available scientific literature concluded that the apparent decrease in Alzheimer disease risk may be simply because smokers tend to die before reaching the age at which it normally occurs. "Differential mortality is always likely to be a problem where there is a need to investigate the effects of smoking in a disorder with very low incidence rates before age 75 years, which is the case of Alzheimer's disease", it stated, noting that smokers are only half as likely as nonsmokers to survive to the age of 80.[121]

Gateway theory

[edit]

A very strong argument has been made about the association between adolescent exposure to nicotine by smoking conventional cigarettes and the subsequent onset of using other dependence-producing substances.[122] Strong temporal and dose-dependent associations have been reported, and a plausible biological mechanism (via rodent and human modeling) suggests that long-term changes in the neural reward system take place as a result of adolescent smoking.[122] Adolescent smokers of conventional cigarettes have disproportionately high rates of comorbid substance use, and longitudinal studies have suggested that early adolescent smoking may be a starting point or "gateway" for substance use later in life, with this effect more likely for persons with attention deficit hyperactivity disorder (ADHD).[122] Although factors such as genetic comorbidity, innate propensity for risk-taking, and social influences may underlie these findings, both human neuroimaging and animal studies suggest a neurobiological mechanism also plays a role.[122] In addition, behavioral studies in adolescent and young adult smokers have revealed an increased propensity for risk-taking, both generally and in the presence of peers, and neuroimaging studies have shown altered frontal neural activation during a risk-taking task as compared with nonsmokers.[122] In 2011, Rubinstein and colleagues used neuroimaging to show decreased brain response to a natural reinforcer (pleasurable food cues) in adolescent light smokers (1–5 cigarettes per day), with their results highlighting the possibility of neural alterations consistent with nicotine dependence and altered brain response to reward even in adolescent low-level smokers.[122]

Second-hand smoke

[edit]

Second-hand smoke is a mixture of smoke from the burning end of a cigarette and the smoke exhaled from the lungs of smokers. It is involuntarily inhaled, lingers in the air for hours after cigarettes have been extinguished, and can cause a wide range of adverse health effects, including cancer, respiratory infections, and asthma.[123] Nonsmokers who are exposed to second-hand smoke at home or work increase their heart disease risk by 25–30% and their lung cancer risk by 20–30%. Second-hand smoke has been estimated to cause 38,000 deaths per year, of which 3,400 are deaths from lung cancer in nonsmokers.[124] Sudden infant death syndrome, ear infections, respiratory infections, and asthma attacks can occur in children who are exposed to second-hand smoke.[125][126][127] Scientific evidence shows that no level of exposure to second-hand smoke is safe.[125][126]

Legislation

[edit]

Smoking restrictions

[edit]

Many governments impose restrictions on smoking tobacco, especially in public areas. The primary justification has been the negative health effects of second-hand smoke.[128] Laws vary by country and locality. Nearly all countries have laws restricting places where people can smoke in public, and over 40 countries have comprehensive smoke-free laws that prohibit smoking in virtually all public venues.

Smoking age

[edit]

In the United States, the age to buy tobacco products is 21 in all states as of 2020.

Similar laws exist in many other countries. In Canada, most of the provinces require smokers to be 19 years of age to purchase cigarettes (except for Quebec and the prairie provinces, where the age is 18). However, the minimum age only concerns the purchase of tobacco, not use. Alberta, however, does have a law which prohibits the possession or use of tobacco products by all persons under 18, punishable by a $100 fine. Australia, New Zealand, Poland, and Pakistan have a nationwide ban on the selling of all tobacco products to people under the age of 18.

Tabak-Trafik in Vienna: Since January 1, 2007, all cigarette machines in Austria must attempt to verify a customer's age by requiring the insertion of a debit card or mobile phone verification.

Since October 1, 2007, it has been illegal for retailers to sell tobacco in all forms to people under the age of 18 in three of the UK's four constituent countries (England, Wales, Northern Ireland, and Scotland), rising from 16. It is also illegal to sell lighters, rolling papers, and all other tobacco-associated items to people under 18. It is not illegal for people under 18 to buy or smoke tobacco, just as it was not previously for people under 16; it is only illegal for the said retailer to sell the item. The age increase from 16 to 18 came into force in Northern Ireland on September 1, 2008. In the Republic of Ireland, bans on the sale of the smaller 10-packs and confectionery that resembles tobacco products (candy cigarettes) came into force on May 31, 2007, in a bid to cut underaged smoking. In October 2023 it was announced that the government proposed introducing a ban on sales of cigarettes to anyone born after 2008.[129]

Most countries in the world have a legal vending age of 18. In North Macedonia, Italy, Malta, Austria, Luxembourg, and Belgium, the age for legal vending is 16. Since January 1, 2007, all cigarette machines in public places in Germany must attempt to verify a customer's age by requiring the insertion of a debit card. Turkey, which has one of the highest percentage of smokers in its population,[130] has a legal age of 18. Japan is one of the highest tobacco-consuming nations, and requires purchasers to be 20 years of age. Since July 2008, Japan has enforced this age limit at cigarette vending machines through use of the taspo smart card. In other countries, such as Egypt, it is legal to use and purchase tobacco products regardless of age.[citation needed] Germany raised the purchase age from 16 to 18 on September 1, 2007.

Some police departments in the United States occasionally send an underaged teenager into a store where cigarettes are sold, and have the teen attempt to purchase cigarettes, with their own or no ID. If the vendor then completes the sale, the store is issued a fine.[131] Similar enforcement practices are regularly performed by Trading Standards officers in the UK, Israel, and the Republic of Ireland.[132]

Taxation

[edit]
Average price of cigarettes in USD in 2012 and 2014[133]

Cigarettes are taxed both to reduce use, especially among youth, and to raise revenue. Higher prices for cigarettes discourage smoking. Every 10% increase in the price of cigarettes reduces youth smoking by about 7% and overall cigarette consumption by about 4%.[134] The World Health Organization (WHO) recommends that globally cigarettes be taxed at a rate of three-quarters of cigarettes sale price as a way of deterring cancer and other negative health outcomes.[135]

Cigarette sales are a significant source of tax revenue in many localities. This fact has historically been an impediment for health groups seeking to discourage cigarette smoking, since governments seek to maximize tax revenues. Furthermore, some countries have made cigarettes a state monopoly, which has the same effect on the attitude of government officials outside the health field.[136]

In the United States, states are a primary determinant of the total tax rate on cigarettes. Generally, states that rely on tobacco as a significant farm product tend to tax cigarettes at a low rate.[137] Coupled with the federal cigarette tax of $1.01 per pack, total cigarette-specific taxes range from $1.18 per pack in Missouri to $8.00 per pack in Silver Bay, New York. As part of the Family Smoking Prevention and Tobacco Control Act, the federal government collects user fees to fund Food and Drug Administration (FDA) regulatory measures over tobacco.

Fire-safe cigarette

[edit]

Cigarettes are a frequent source of deadly fires in private homes, which prompted both the European Union and the United States to require cigarettes to be fire-standard compliant.[138][139]

According to Simon Chapman, a professor of public health at the University of Sydney, reduction of burning agents in cigarettes would be a simple and effective means of dramatically reducing the ignition propensity of cigarettes.[140] Since the 1980s, prominent cigarette manufacturers such as Philip Morris and R.J. Reynolds have developed fire safe cigarettes, but Phillip Morris was later the subject of a government lawsuit for allegedly hiding the even greater dangers associated with their brand of such cigarettes.[141]

The burn rate of cigarette paper is regulated through the application of different forms of microcrystalline cellulose to the paper.[142] Cigarette paper has been specially engineered by creating bands of different porosity to create "fire-safe" cigarettes. These cigarettes have a reduced idle burning speed which allows them to self-extinguish.[143] This fire-safe paper is manufactured by mechanically altering the setting of the paper slurry.[144]

New York was the first U.S. state to mandate that all cigarettes manufactured or sold within the state comply with a fire-safe standard. Canada has passed a similar nationwide mandate based on the same standard. All U.S. states are gradually passing fire-safe mandates.[145]

The European Union in 2011 banned cigarettes that do not meet a fire-safety standard. According to a study made by the European Union in 16 European countries, 11,000 fires were due to people carelessly handling cigarettes between 2005 and 2007. This caused 520 deaths with 1,600 people injured.[146]

Cigarette advertising

[edit]

Many countries have restrictions on cigarette advertising, promotion, sponsorship, and marketing. For example, in the Canadian provinces of British Columbia, Saskatchewan and Alberta, the retail store display of cigarettes is completely prohibited if persons under the legal age of consumption have access to the premises.[147] In Ontario, Manitoba, Newfoundland and Labrador, and Quebec, Canada and the Australian Capital Territory the display of tobacco is prohibited for everyone, regardless of age, as of 2010. This retail display ban includes noncigarette products such as cigars and blunt wraps.[148][149]

Warning messages on packaging

[edit]

As a result of tight advertising and marketing prohibitions, tobacco companies look at the packaging differently: they view it as a strong component in displaying brand imagery and a creating in-store presence at the point of purchase. Market testing shows the influence of this dimension in shifting the consumer's choice when the same product displays in alternative packaging. Companies have manipulated a variety of elements on packaging designs to communicate the impression of lower in tar or milder cigarettes, whereas the components were the same.[150]

Some countries require cigarette packs to contain warnings about the health impact of smoking. The United States was the first,[151] later followed by other countries including Canada, most of Europe, the United Kingdom, Australia,[152] Pakistan,[153] India and Hong Kong. In 1985, Iceland became the first country to enforce graphic warnings on cigarette packaging.[154][155] At the end of December 2010, new regulations from Ottawa increased the size of tobacco warnings to cover three-quarters of the cigarette packaging in Canada.[156] As of November 2010, 39 countries have adopted similar legislation.[151]

In February 2011, the Canadian government passed regulations requiring cigarette packaging to contain 12 new images to cover three quarters of the outside panel and eight new health messages on the inside panel with full color.[157]

As of April 2011, Australian regulations require all packaging to use a bland olive green that researchers determined to be the least attractive color,[158] with 75% coverage on the front of the pack and all of the back consisting of graphic health warnings. The only feature that differentiates one brand from another is the product name in a standard color, position, font size, and style.[159] In response to these regulations, Philip Morris International, Japan Tobacco Inc., British American Tobacco Plc., and Imperial Tobacco attempted to sue the Australian government. On August 15, 2012, the High Court of Australia dismissed the suit and made Australia the first country to introduce brand-free plain cigarette packaging with health warnings covering 90% of the back and 70% of the front packaging. This took effect on December 1, 2012.[160]

Similar policies have since been introduced in the United Kingdom. The United Kingdom introduced the standardised packaging of tobacco products regulations (SPOT) in 2015. These regulations were also challenged by cigarette manufacturers.[161][162]

Prohibition of tobacco

[edit]

A few countries have outlawed tobacco completely or made plans to do so. In 2004, Bhutan became the first country in the world to completely outlaw the cultivation, harvesting, production, and sale of tobacco and tobacco products. Enforcement of the prohibition increased with the passage of the Tobacco Control Act of Bhutan 2010. However, small allowances for personal possession are permitted as long as the possessors can prove that they have paid import duties.[163] The Pitcairn Islands had previously banned the sale of cigarettes, but it now permits sales from a government-run store. The Pacific island of Niue hopes to become the next country to prohibit the sale of tobacco.[164] Iceland is also proposing banning tobacco sales from shops, making it prescription-only and therefore dispensable only in pharmacies on doctor's orders.[165] Singapore and the Australian state of Tasmania have proposed a 'tobacco free millennium generation initiative' by banning the sale of all tobacco products to anyone born in and after the year 2000. In March 2012, Brazil became the world's first country to ban all flavored tobacco including menthols. It also banned the majority of the estimated 600 additives used, permitting only eight. This regulation applies to domestic and imported cigarettes. Tobacco manufacturers had 18 months to remove the noncompliant cigarettes, 24 months to remove the other forms of noncompliant tobacco.[166][167] Under sharia law, the consumption of cigarettes by Muslims is prohibited.[168]

Environmental effects

[edit]
Simple molecular representation of cellulose acetate with one of the acetate groups on the cellulose backbone shown by the red circle

Cigarette filters are made up of thousands of polymer chains of cellulose acetate, which has the chemical structure shown to the right. Once discarded into the environment, the filters create a large waste problem. Cigarette filters are the most common form of litter in the world, as approximately 5.6 trillion cigarettes are smoked every year worldwide.[169] Of those, an estimated 4.5 trillion cigarette filters become litter every year.[170] To develop an idea of the waste weight amount produced a year the table below was created.

Estimated waste produced from filters
Number of filters weight
1 pack (20) 3.4 grams (0.12 oz)
sold daily (15 billion) 2,551,000 kilograms (5,625,000 lb)
sold yearly (5.6 trillion) 950,000,000 kilograms (2,100,000,000 lb)
estimated trash (4.5 trillion) 765,400,000 kilograms (1,687,500,000 lb)

Discarded cigarette filters usually end up in the water system through drainage ditches and are transported by rivers and other waterways to the ocean.

Aquatic life health concerns

[edit]

In the 2006 International Coastal Cleanup, cigarettes and cigarette butts constituted 24.7% of the total collected pieces of garbage, over twice as many as any other category, which is not surprising seeing the numbers in the table above of waste produced each year.[171] Cigarette filters contain the chemicals filtered from cigarettes and can leach into waterways and water supplies.[172] The toxicity of used cigarette filters depends on the specific tobacco blend and additives used by the cigarette companies. After a cigarette is smoked, the filter retains some of the chemicals, and some of those are considered carcinogenic.[46] When studying the environmental effects of cigarette filters, the various chemicals that can be found in cigarette filters are not studied individually, due to the complexity of doing so. Researchers instead focus on the whole cigarette filter and its LD50. LD50 is defined as the lethal dose that kills 50% of a sample population. This allows for a simpler study of the toxicity of cigarette filters. One recent study has looked at the toxicity of smoked cigarette filters (smoked filter + tobacco), smoked cigarette filters (no tobacco), and unsmoked cigarette filters (no tobacco). The results of the study showed that for the LD50 of both marine topsmelt (Atherinops affinis) and freshwater fathead minnow (Pimephales promelas), smoked cigarette filters + tobacco are more toxic than smoked cigarette filters, but both are severely more toxic than unsmoked cigarette filters.[173]

LD50 of cigarette filters to marine life (cigarette per liter)
Cigarette type Marine topsmelt Fathead minnow
Smoked cigarette filter (smoked filter + tobacco) 1.0 1.0
Smoked cigarette filters (no tobacco) 1.8 4.3
Unsmoked cigarette filters (no tobacco) 5.1 13.5

Other health concerns

[edit]

Toxic chemicals are not the only human health concern to take into considerations; the others are cellulose acetate and carbon particles that are breathed in while smoking. These particles are suspected of causing lung damage.[174] The next health concern is that of plants. Under certain growing conditions, plants on average grow taller and have longer roots than those exposed to cigarette filters in the soil. A connection exists between cigarette filters introduced to soil and the depletion of some soil nutrients over time. Another health concern to the environment is not only the toxic carcinogens that are harmful to the wildlife, but also the filters themselves pose an ingestion risk to wildlife that may presume filter litter as food.[175] The last major health concern to make note of for marine life is the toxicity that deep marine topsmelt and fathead minnow pose to their predators. This could lead to toxin build-up (bioaccumulation) in the food chain and have long reaching negative effects. Smoldering cigarette filters have also been blamed for triggering fires from residential areas[176] to major wildfires and bushfires which has caused major property damage and also death[177][178][179] as well as disruption to services by triggering alarms and warning systems.[180]

Degradation

[edit]

Once in the environment, cellulose acetate can go through biodegradation and photodegradation.[181][182][183] Several factors go into determining the rate of each degradation process. This variance in rate and resistance to biodegradation in many conditions is a factor in littering[184] and environmental damage.[185]

Discarded Newport cigarettes packs found in Olneyville, Rhode Island - 2008

Biodegradation

[edit]
Chemical hydrolysis of cellulose acetate

The first step in the biodegradation of cellulose acetate is the deactylation of the acetate from the polymer chain (which is the opposite of acetylation). An acetate is a negative ion with the chemical formula of C2H3O2. Deacetylation can be performed by either chemical hydrolysis or acetylesterase. Chemical hydrolysis is the cleavage of a chemical bond by addition of water. In the reaction, water (H2O) reacts with the acetic ester functional group attached the cellulose polymer chain and forms an alcohol and acetate. The alcohol is simply the cellulose polymer chain with the acetate replaced with an alcohol group. The second reaction is exactly the same as chemical hydrolysis with the exception of the use of an acetylesterase enzyme. The enzyme, found in most plants, catalyzes the chemical reaction shown below.[186]

acetic ester + H2O ⇌ alcohol + acetate

In the case of the enzymatic reaction, the two substrates (reactants) are again acetic ester and H2O, the two products of the reaction are alcohol and acetate. This reaction is exactly the same as the chemical hydrolysis. Both of these products are perfectly fine in the environment. Once the acetate group is removed from the cellulose chain, the polymer can be readily degraded by cellulase, which is another enzyme found in fungi, bacteria, and protozoans. Cellulases break down the cellulose molecule into monosaccharides ("simple sugars") such as beta-glucose, or shorter polysaccharides and oligosaccharides.

The chemical structure change of cellulose into glucose

These simple sugars are not harmful to the environment and are in fact are a useful product for many plants and animals. The breakdown of cellulose is of interest in the field of biofuel.[187] Due to the conditions that affect the process, large variation in the degradation time of cellulose acetate occurs.

Factors in biodegradation

[edit]

The duration of the biodegradation process is cited as taking as little as one month[181] to as long as 15 years or more, depending on the environmental conditions. The major factor that affects the biodegradation duration is the availability of acetylesterase and cellulase enzymes. Without these enzymes, biodegradation only occurs through chemical hydrolysis and stops there. Temperature is another major factor: if the organisms that contain the enzymes are too cold to grow, then biodegradation is severely hindered. Availability of oxygen in the environment also affects the degradation. Cellulose acetate is degraded within 2–3 weeks under aerobic assay systems of in vitro enrichment cultivation techniques and an activated sludge wastewater treatment system.[188] It is degraded within 14 weeks under anaerobic conditions of incubation with special cultures of fungi.[189] Ideal conditions were used for the degradation (i.e., a suitable temperature, and available organisms to provide the enzymes). Thus, filters last longer in places with low oxygen concentration, such as swamps and bogs. Overall, the biodegradation process of cellulose acetate is not an instantaneous process.

Photodegradation

[edit]

The other process of degradation is photodegradation, which is when a molecular bond is broken by the absorption of photon radiation (i.e. light). Due to cellulose acetate carbonyl groups, the molecule naturally absorbs light at 260 nm,[190] but it contains some impurities which can absorb light. These impurities are known to absorb light in the far UV light region (< 280 nm).[191] The atmosphere filters radiation from the sun and allows radiation of > 300 nm only to reach the surface. Thus, the primary photodegradation of cellulose acetate is considered insignificant to the total degradation process, since cellulose acetate and its impurities absorb light at shorter wavelengths. Research is focused on the secondary mechanisms of photodegradation of cellulose acetate to help make up for some of the limitations of biodegradation. The secondary mechanisms would be the addition of a compound to the filters that would be able to absorb natural light and use it to start the degradation process. The main two areas of research are in photocatalytic oxidation[192] and photosensitized degradation.[193] Photocatalytic oxidation uses a species that absorbs radiation and creates hydroxyl radicals that react with the filters and start the breakdown. Photosensitized degradation, though, uses a species that absorbs radiation and transfers the energy to the cellulose acetate to start the degradation process. Both processes use other species that absorbed light > 300 nm to start the degradation of cellulose acetate.[citation needed]

Solution and remediation projects

[edit]
A cigarette disposal canister, encouraging the public to dispose of their cigarettes properly

Several options are available to help reduce the environmental effects of cigarette butts. Proper disposal into receptacles leads to decreased numbers found in the environment and their effect on the environment. Another method is making fines and penalties for littering filters; many governments have sanctioned stiff penalties for littering of cigarette filters; for example, Washington imposes a penalty of $1,025 for littering cigarette filters.[194] Another option is developing better biodegradable filters; much of this work relies heavily on the research in the secondary mechanism for photodegradation as stated above, but a new research group has developed an acid tablet that goes inside the filters, and once wet enough, releases acid that speeds up the degradation to around two weeks.[195] The research is still only in test phase and the hope is soon it will go into production. The next option is using cigarette packs with a compartment in which to discard cigarette butts, implementing monetary deposits on filters, increasing the availability of butt receptacles, and expanding public education. It may even be possible to ban the sale of filtered cigarettes altogether on the basis of their adverse environmental effects.[196] Recent research has been put into finding ways to use the filter waste to develop a desired product. One research group in South Korea has developed a simple one-step process that converts the cellulose acetate in discarded cigarette filters into a high-performing material that could be integrated into computers, handheld devices, electrical vehicles, and wind turbines to store energy. These materials have demonstrated superior performance as compared to commercially available carbon, grapheme, and carbon nanotubes. The product is showing high promise as a green alternative for the waste problem.[197]

Consumption

[edit]
A Woolworths supermarket cigarette counter in New South Wales, Australia: In January 2011, Australia prohibited the display of cigarettes in retail outlets countrywide.[198]
Various cigarettes being sold at a minimarket in the BSD suburb, Tangerang Regency, Indonesia

Smoking has become less popular, but is still a large public health problem globally.[199][200][201] Worldwide, smoking rates fell from 41% in 1980 to 31% in 2012, although the actual number of smokers increased because of population growth.[202] In 2017, 5.4 trillion cigarettes were produced globally, and were smoked by almost 1 billion people.[203] Smoking rates have leveled off or declined in most countries, but is increasing in some low- and middle-income countries. The significant reductions in smoking rates in the United States, United Kingdom, Australia, Brazil, and other countries that implemented strong tobacco control programs[according to whom?] have been offset by the increasing consumption in low income countries, especially China. The Chinese market now consumes more cigarettes than all other low- and middle-income countries combined.

Other regions are increasingly playing larger roles in the growing global smoking epidemic. The WHO Eastern Mediterranean Region (EMRO) now has the highest growth rate in the cigarette market, with more than a one-third increase in cigarette consumption since 2000. Due to its recent dynamic economic development and continued population growth, Africa presents the greatest risk in terms of future growth in tobacco use.

Within countries, patterns of cigarette consumption also can vary widely. For example, in many of the countries where few women smoke, smoking rates are often high in males (e.g., in Asia). By contrast, in most developed countries, female smoking rates are typically only a few percentage points below those of males. In many high and middle income countries lower socioeconomic status is a strong predictor of smoking. 

Smoking rates in the United States have dropped by more than half from 1965 to 2016, falling from 42% to 15.5% of US adults.[204] Australia is cutting their overall smoking consumption faster than most of the developed world, in part due to landmark Plain Packaging Act, which standardized the appearance of cigarette packs. Other countries have considered similar measures. In New Zealand, a bill has been presented to parliament in which the government's associate health minister said "takes away the last means of promoting tobacco as a desirable product."[205]

Smoking prevalence by sex (ages 15 or older, 2016)[206]
Percent smoking
Region Men Women
Africa 18% 2%
Americas 21% 12%
Eastern Mediterranean 34% 2%
Europe 38% 21%
Southeast Asia 32% 2%
Western Pacific 46% 3%
Leading consumers of cigarettes (2016)[207]
Country Population
(millions)
Cigarettes consumed
(billions)
Cigarettes consumed
(per capita)
China 1,386 2,351 2,043
Indonesia 264 316 1,675
Russia 145 278 2,295
United States 327 266 1,017
Japan 127 174 1,583

Lights

[edit]

Some cigarettes are marketed as "lights", "milds", or "low-tar".[208] These cigarettes were historically marketed as being less harmful, but there is no research showing that they are any less harmful. The filter design is one of the main differences between light and regular cigarettes, although not all cigarettes contain perforated holes in the filter. In some light cigarettes, the filter is perforated with small holes that theoretically diffuse the tobacco smoke with clean air. In regular cigarettes, the filter does not include these perforations. In ultralight cigarettes, the filter's perforations are larger. The majority of major cigarette manufacturers offer a light, low-tar, or mild cigarette brand. Due to recent U.S. legislation prohibiting the use of these descriptors, tobacco manufacturers are turning to color-coding to allow consumers to differentiate between regular and light brands.[209]

Research shows that smoking "light" or "low-tar" cigarettes is just as harmful as smoking other cigarettes.[210][211][212]

Notable cigarette brands

[edit]

Smoking cessation

[edit]

Smoking cessation (quitting smoking) is the process of discontinuing the practice of tobacco smoking.[213] Quitting can be difficult for many smokers due to the addictive nature of nicotine.[214]: 2300–2301  The addiction begins when nicotine acts on nicotinic acetylcholine receptors to release neurotransmitters such as dopamine, glutamate, and gamma-aminobutyric acid.[214]: 2296  Cessation of smoking leads to symptoms of nicotine withdrawal such as anxiety and irritability.[214]: 2298  Professional smoking cessation support methods generally endeavour to address both nicotine addiction and nicotine withdrawal symptoms.

Smoking cessation can be achieved with or without assistance from healthcare professionals or the use of medications.[215] Methods that have been found to be effective include interventions directed at or through health care providers and health care systems; medications including nicotine replacement therapy (NRT) and varenicline; individual and group counselling; and web-based or stand-alone computer programs. Although stopping smoking can cause short-term side effects such as reversible weight gain, smoking cessation services and activities are cost-effective because of the positive health benefits.

At the University of Buffalo, researchers found out that fruit and vegetable consumption can help a smoker cut down or even quit smoking[216]

  • A growing number of countries have more ex-smokers than smokers.[217]
  • Early "failure" is a normal part of trying to stop, and more than one attempt at stopping smoking prior to longer-term success is common.[215]
  • NRT, other prescribed pharmaceuticals, and professional counselling or support also help many smokers.[215]
  • However, up to three-quarters of ex-smokers report having quit without assistance ("cold turkey" or cut down then quit), and cessation without professional support or medication may be the most common method used by ex-smokers.[215]

The number of nicotinic receptors in the brain returns to the level of a nonsmoker between 6 and 12 weeks after quitting.[218] In 2019, the FDA authorized the selling of low-nicotine cigarettes in hopes of lowering the number of people addicted to nicotine.[219]

See also

[edit]

References

[edit]

Sources

[edit]

Further reading

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
A cigarette consists of a blend of , often shredded and processed with chemical additives, wrapped in thin paper, typically featuring a filter at one end, designed for at the opposite end with smoke inhaled through the mouth. The modern form traces to 19th-century innovations, with commercial catalyzed by James Bonsack's 1880 cigarette-rolling machine, which enabled widespread availability following earlier hand-rolled practices among indigenous groups and European adaptations. Upon burning, cigarettes generate smoke containing —a highly addictive —along with over 7,000 chemicals, including at least 70 known carcinogens like , , and , which causally drive diseases through mechanisms such as DNA damage, inflammation, and . remains the foremost modifiable for premature mortality, accounting for roughly 8 million deaths yearly worldwide, with primary attributions to (causing nearly 90% of cases), (one in four deaths), and , alongside secondhand exposure effects. Though has fallen—from 22.7% globally in 2007 to 17% in 2021—over 1 billion adults still , concentrated in low- and middle-income regions, sustaining a sector with annual sales exceeding $700 billion while imposing health and productivity losses surpassing $1 trillion. Regulatory measures, including taxes, packaging warnings, and advertising bans, have curbed uptake, yet controversies persist over industry tactics to maintain via additives and historical suppression of data, underscoring causal links from empirical over decades.

History

Origins in the Americas and Early European Adoption

Tobacco (Nicotiana tabacum), native to the Americas, was cultivated and used by indigenous peoples for thousands of years prior to European contact, with archaeological evidence indicating human utilization dating back at least 12,300 years. Smoking practices emerged prominently among groups such as the Maya in Central America around the 1st century BC, where dried tobacco leaves were rolled into bundles or used in pipes for ceremonial, medicinal, and religious purposes, often by priests and shamans to invoke spiritual connections. Biomolecular analysis of ancient residues confirms direct inhalation of tobacco smoke by hunter-gatherers in northwestern North America as early as several millennia ago. Pre-Columbian smoking forms included rolled leaves or shredded plant material wrapped in corn husks or palm, precursors to the modern cigarette, particularly among the people of the who fashioned "tutun"—dried leaves rolled for . These practices were integral to rituals, healing, and social customs across and , with evidence from Mayan pictographs depicting individuals smoking elongated rolls of . By the time of European arrival, smoking was well-established among indigenous elites and commoners alike. European encounter with these practices occurred on October 12, 1492, when landed in and later observed natives in offering dried leaves and demonstrating of rolled forms during his expedition. Crew member Rodrigo de Jerez adopted the habit, returning to as one of the first Europeans to smoke, though initially met with suspicion and imprisonment for the practice. seeds and habits spread via Spanish and sailors in the early , reaching by 1558 and through diplomat in 1560, who promoted it medicinally—lending his name to . Adoption accelerated across by the mid-, with pipe smoking predominant but rolled tobacco (cigarillos) also used, especially in and , where hand-rolled forms echoed indigenous methods. English explorer John Hawkins introduced it to around 1565, and by the 1590s, figures like popularized recreational smoking amid debates over its health benefits and vices. Initial European uses mirrored indigenous ceremonial and purported therapeutic roles, treating ailments like headaches and wounds, though recreational appeal grew rapidly despite early papal bans and moral opposition. By the late , cultivation began in European colonies, facilitating broader adoption.

Commercialization and Global Spread (19th Century)

The mid-19th century marked the initial commercialization of cigarettes in Europe, driven by exposure during the (1853–1856), when British and French soldiers adopted the Ottoman practice of rolling in thin paper. Returning troops popularized the habit, shifting preferences from pipes and cigars toward portable cigarettes. In Britain, Philip Morris was founded in 1847 by a London tobacconist, initially retailing hand-rolled Turkish-style cigarettes imported from the , which catered to growing demand among the upper classes and military personnel. Production remained artisanal, with workers hand-rolling up to 4 cigarettes per minute, constraining output to small-scale operations. Mechanized production revolutionized commercialization in the late , enabling mass output and market dominance. In 1880, American inventor developed the first viable cigarette-rolling machine, patented in 1881, which automated the process of cutting, rolling, and pasting paper around tobacco at rates up to 120 cigarettes per minute—equivalent to the daily output of dozens of hand-rollers. Initial adoption faced hurdles due to frequent jams and inconsistent quality, but refinements allowed entrepreneur to license the technology in 1884 for his family's W. Duke, Sons, and Company in . Duke invested in multiple machines, paying a $200 weekly royalty per unit, and by 1885 his firm produced over 10 million cigarettes monthly, slashing costs and undercutting rivals through price wars and innovative packaging. This efficiency propelled Duke to control about 40% of the U.S. cigarette market by the decade's end, culminating in the 1890 formation of the trust. The scalability of machine production facilitated cigarettes' global spread, as surplus output fueled exports via established trade networks. European firms, including those in Britain and , adopted similar technologies, while U.S. brands like Duke's "Cross Cut" and "Duke of Durham" reached , , and through colonial outposts and emigration waves. By the , cigarette consumption had risen sharply in urban centers worldwide, with branded products displacing loose tobacco; for instance, British exports targeted and , where local adoption grew among laborers and elites. This era's innovations laid the groundwork for multinational giants like , formed in 1902 from mergers of late-19th-century operations.

Peak Consumption and Government Promotion (Early 20th Century to WWII)

![Camel cigarette advertisement from 1942][float-right] In the , per capita cigarette consumption rose steadily from approximately 54 cigarettes per person in 1900 to 665 by 1920, reflecting the widespread adoption facilitated by mechanized production and aggressive marketing campaigns. By 1935, this figure had reached 1,564 cigarettes per capita, increasing to 1,976 in 1940 amid economic recovery and intensified advertising that often featured endorsements from physicians claiming benefits or throat-soothing properties. companies invested heavily in print media, with advertisements portraying as a modern, stress-relieving habit suitable for both men and women, contributing to cultural normalization. Government involvement significantly boosted consumption during the World Wars, positioning cigarettes as essential for troop morale. In , the U.S. military procured vast quantities from manufacturers like , which sold its entire production to the War Department, distributing tobacco through canteens to combat boredom and enhance soldier welfare. This wartime supply chain not only sustained high usage among servicemen but also reinforced domestic demand upon their return. During , cigarettes became standard components of C-rations and s, with each K-ration box including several packs alongside gum and candy to alleviate combat stress and maintain fighting efficiency; the U.S. military distributed billions, further entrenching smoking as a military norm. This governmental endorsement, coupled with private sector promotion, drove a sharp consumption spike, reaching 3,449 cigarettes by 1945 as returning veterans sustained elevated habits and expenditures soared. policies implicitly subsidized the industry by prioritizing tobacco in , with little contemporaneous recognition of long-term risks despite emerging anecdotal concerns. The era's fusion of state support and commercial hype laid the foundation for post-war peaks, as permeated civilian society.

Post-War Boom and Initial Health Concerns (1950s-1960s)

In the years following , cigarette consumption in the United States experienced a significant surge, driven by aggressive campaigns, cultural normalization, and innovations in . Annual per capita consumption rose from 3,522 cigarettes in 1950 to a peak of 4,345 by 1963, reflecting widespread adoption across demographics, including increased among women and postwar economic prosperity that facilitated leisure activities like . By the mid-1960s, over 40 percent of U.S. adults were regular smokers, with cigarettes often portrayed in media and advertising as symbols of sophistication and stress relief. Tobacco companies invested heavily in promotions, including filtered cigarettes introduced in the early 1950s, which were marketed as safer despite lacking substantive evidence of reduced harm at the time. Emerging epidemiological in the 1950s began to challenge this boom by identifying strong statistical associations between cigarette and . A landmark 1950 case-control study in the by and Austin Bradford Hill analyzed 684 cases and found smokers were substantially more likely to develop the disease than non-smokers, with odds ratios indicating a dose-response relationship. Similar retrospective studies in the United States, such as those by Ernst Wynder and Evarts Graham in 1950, corroborated these findings, reporting that over 90 percent of patients were heavy smokers. Animal experiments in the same decade further supported potential causality, demonstrating that cigarette tar could induce tumors in mice, though human causation remained debated due to confounding factors like occupational exposures and limited mechanistic understanding. By 1957, scientists within the U.S. Public Health Service had internally concluded that caused , predating broader public acknowledgment. The responded to these initial concerns with public denials and efforts to sow doubt, forming alliances like the Tobacco Industry Research Committee in 1954 to fund studies questioning the evidence. A coordinated advertisement campaign that year, titled "A Frank Statement to Cigarette Smokers," asserted that "we believe the products we make are not injurious to " and called for independent , effectively framing the science as unsettled despite accumulating data. This strategy delayed regulatory action and public awareness, allowing consumption to continue rising into the early , even as cohort studies reinforced the smoking-lung cancer link with relative risks exceeding 10-fold for heavy smokers. Critics later noted that industry-funded often emphasized alternative causes, such as , to divert attention from tobacco's role.

Decline and Regulatory Shifts (1970s-Present)

Cigarette declined from 37.4% among adults in 1970 to 25.5% by 1990, continuing to fall to 11.6% by 2022, representing a 73% reduction from 1965 levels. Globally, dropped by 27.2% among men and 37.9% among women since 1990, with larger declines in high-income countries, though absolute consumption remains high in low- and middle-income nations at over 1 billion smokers in 2020. These trends reflect reduced initiation among youth and higher quit rates, driven by accumulating epidemiological evidence linking to , , and other conditions, as detailed in reports from the 1970s onward. In the United States, the of 1970 banned cigarette advertising on television and radio effective January 2, 1971, and mandated package warnings stating that is "dangerous to health." Subsequent regulations included expanded warnings in 1984 requiring rotation of specific health risks like and fetal injury, alongside state-level indoor bans beginning in the late , such as California's 1976 restrictions in certain public spaces. Federal aviation rules prohibited on domestic flights under two hours in 1988, later extended nationwide. These measures curtailed youth exposure to marketing and normalized non- environments, contributing to prevalence drops exceeding 1% annually in the and . The 1990s saw intensified litigation, culminating in the 1998 Master Settlement Agreement between tobacco companies and 46 states, which imposed $206 billion in payments for health costs, restricted youth-targeted marketing, and funded anti-smoking campaigns like the . The Family Smoking Prevention and Tobacco Control Act of 2009 granted the FDA authority over tobacco products, enabling flavor bans in cigarettes (except , pending rulemaking), graphic warning labels, and premarket review of new products. Smoke-free laws proliferated, covering workplaces and restaurants in most states by the , while excise taxes rose, with a federal increase to $1.01 per pack in 2009 correlating with accelerated youth declines. Internationally, the World Health Organization's Framework Convention on Tobacco Control, ratified by over 180 countries since 2003, standardized measures like advertising bans, taxation, and cessation support, yielding a 4-5% consumption drop per 10% price hike. In and , plain packaging laws from 2012 onward further diminished brand appeal. Despite these shifts, challenges persist, including illicit trade and slower declines in developing markets where affordability remains high. Empirical analyses attribute the decline primarily to price elasticity from taxes, reduced accessibility via bans, and public education campaigns highlighting causal links between and mortality, though social denormalization amplified effects beyond direct . Cessation aids and replacement therapies, regulated post-1970s, supported quitting, with U.S. quit attempts rising amid these interventions. Regulatory focus has increasingly targeted combustible cigarettes while scrutinizing alternatives like e-cigarettes for youth uptake risks.

Composition and Manufacturing

Tobacco Blends and Varieties

Cigarette tobacco blends are formulated by combining varieties selected for complementary flavor profiles, levels, burn characteristics, and combustibility. The predominant blend in mass-produced cigarettes is the American style, which integrates flue-cured tobacco for sweetness, air-cured Burley for robustness, and sun-cured Oriental varieties for aromatic complexity. This combination balances high sugar content from with the low-sugar, high- absorption of Burley, while Orientals contribute spice without dominating. Flue-cured tobacco, derived from Nicotiana tabacum plants grown primarily in the , , and , undergoes curing in heated barns with controlled indirect heat to retain natural sugars and develop a mild, sweet, citrus-like flavor. It features bright yellow-to-orange leaves with medium to high content and serves as the primary base in blends, comprising the majority of the mix to ensure smooth and a light-bodied . Sub-varieties include (lighter, higher sugar) and darker red types (deeper flavor), harvested from the plant's upper leaves for optimal quality. Air-cured Burley tobacco, originating from regions like Kentucky and Tennessee in the U.S., is hung in ventilated barns for 4-8 weeks, resulting in light brown to reddish-brown leaves with negligible sugar, high nicotine, and an earthy, nutty taste. Its absorbent quality allows it to hold added flavors or humectants, providing structural body and nicotine strength to blends while moderating the sweetness of Virginia. White Burley, developed in the 1860s, dominates due to its mildness compared to darker subtypes. Sun-cured Oriental tobaccos, cultivated in , , and the from small-leafed varieties like , Basma, and , are dried outdoors to yield spicy, tangy, and highly aromatic profiles with low and fast burn rates. These are incorporated in smaller proportions—often 10-20%—to enhance overall aroma and exotic notes without overpowering the blend's . Fire-cured varieties, exposed to smoke during curing, add rare smoky undertones but are used sparingly in cigarettes due to intensity. Regional variations exist; for instance, some international cigarettes, such as those in , rely almost exclusively on flue-cured for a lighter profile, omitting Burley and Orientals. Blending ratios are adjusted by manufacturers to meet specific taste targets, with typically predominant, Burley for balance, and Orientals for nuance, ensuring consistent draw and ash quality.

Paper, Filters, and Structural Components

A cigarette consists of a rod encased in , with a filter attached at one end, covered by tipping paper that overlaps the rod slightly for attachment. The rod is formed by cutting and blending filler, then wrapping it in using a gummed seam for . The filter is inserted into the rod end, and tipping paper is applied over the filter and a portion of the rod, secured with adhesive. Plugwrap encases the filter material internally. Cigarette paper is primarily composed of bleached wood pulp and pulp fibers, processed into thin, porous sheets to facilitate controlled . These fibers are pulped, refined, and formed into paper with additives such as to enhance and burning rate, ensuring the paper burns evenly without excessive ash. The paper's basis weight typically ranges from 20 to 30 grams per square meter, optimized for low ignition propensity in modern designs. Cigarette filters are constructed from tow, a produced by acetylating derived from wood pulp with acetic acid and , resulting in plastic-like rods of bundled fibers. The tow is crimped, gathered into a cylindrical plug, and wrapped in porous plugwrap paper to maintain structure while allowing smoke passage. dominates due to its high surface area for trapping particulates, with fibers averaging 15,000 to 40,000 denier in fineness. Some filters incorporate activated granules for gas-phase adsorption, embedded within the acetate or in cavity designs. Tipping paper, applied over the filter, is made from fibers sourced from wood pulp, often printed with cork-like patterns using inks containing for opacity and aesthetics. It includes laser-perforated ventilation holes in low-tar variants to dilute smoke with air, altering draw resistance and yield measurements. Adhesives, typically starch-based or synthetic, secure the tipping to the rod and form longitudinal seams in both and tipping.

Additives and Chemical Engineering

Cigarette additives encompass a range of organic and inorganic compounds intentionally incorporated during manufacturing to alter tobacco's chemical profile, combustion behavior, and sensory attributes. These substances, often exceeding 100 in number per brand, include humectants such as and to retain moisture and prevent brittleness; sugars like and invert sugar for flavor enhancement and to generate caramel-like notes during ; and pH modifiers including ammonia salts to adjust smoke . Burn additives, such as potassium citrate, are added to the or to control ignition propensity and reduce sidestream smoke density, influencing overall and efficiency. Chemical engineering processes integrate these via casing—spraying aqueous solutions onto cut tobacco lamina, followed by drying and expansion—or through reconstituted sheet tobacco production, where pulp is mixed with additives before and cutting. Ammonia engineering exemplifies targeted chemical manipulation: salts or aqueous are applied to , liberating free during curing or heating, which elevates mainstream smoke from approximately 5.5 to 7.5, converting a greater fraction of to its volatile freebase form for enhanced pulmonary absorption. This adjustment, documented in industry practices since the 1960s, correlates with increased bioavailability without altering total content, potentially amplifying addictive potential through faster delivery to the . Sugars, added at levels up to 20% by weight in some blends, not only mask bitterness but undergo to yield aldehydes like , which may potentiate 's reinforcing effects by inhibiting reuptake or forming protonated salts for smoother inhalation. Engineering extends to mitigating or redistributing combustion byproducts: antioxidants such as (ascorbic acid) are trialed to scavenge free radicals, though efficacy in is limited by conditions exceeding 900°C in the cigarette core. Flavors like or are microencapsulated or top-dressed post-casing to survive processing and volatilize during puffing, reducing perceived harshness from irritants like . Regulatory disclosures, mandated in jurisdictions like the since 2006, reveal additive lists but often omit proprietary formulations or synergistic interactions, complicating independent verification of causal impacts on toxicity. Overall, these interventions reflect iterative optimization for product stability, yield consistency, and user retention, grounded in empirical chemistry analyses rather than health minimization.

Modern Production Techniques and Quality Control

Modern cigarette production relies on highly automated assembly lines capable of outputting up to 20,000 cigarettes per minute, utilizing precision machinery to handle tobacco processing, rod formation, filter attachment, and packaging. The process begins with tobacco leaf inspection and blending, where cut shreds from various varieties are mixed to achieve consistent flavor and burn characteristics, followed by conditioning to regulate moisture content at around 12-15%. A continuous spool of cigarette paper, often exceeding 7,000 meters in length, is unrolled as shredded tobacco is fed onto it via pneumatic systems, with adhesive applied for seam formation to create a continuous rod approximately 490 meters per minute in length. Subsequent stages involve attaching cellulose acetate filters using laser-guided applicators for alignment, then high-speed cutting blades that slice the filtered rod into individual cigarettes of standard lengths such as 84 mm or 100 mm. Packaging lines integrate secondary , including wrapping, carton formation, and labeling at rates synchronized with to minimize bottlenecks, often employing robotic arms for handling and conveyor systems for material flow. Modern systems incorporate and servo-driven controls to adjust variables like tobacco density in real-time, reducing waste and enabling production of variants such as slim or flavored cigarettes without retooling delays. Quality control integrates inline sensors and automated inspections throughout the line to monitor parameters including cigarette (typically 0.8-1.2 grams per unit), (7.5-8.0 mm), draw resistance ( of 80-120 mm water gauge), and end stability to ensure uniformity and prevent defects like loose ends or uneven burns. systems using detect anomalies such as paper tears, discoloration, or filter misalignments at production speeds, rejecting non-conforming items via pneumatic ejection. sampling verifies chemical composition, including levels and additive distribution, while human oversight persists for subjective assessments like leaf and blend integrity, as machines cannot fully replicate sensory evaluation. Post-production testing on machines simulates consumer use to measure yield consistency, with driving adherence to standards like ISO 3402 for physical properties. These measures, combining digital precision with empirical validation, maintain product specifications amid competitive pressures and evolving regulations.

Types and Variants

Traditional Combustible Cigarettes

Traditional combustible cigarettes consist of dried and fermented leaves, finely cut and rolled into a thin cylinder, which is ignited at one end and inhaled from the other to produce smoke through combustion. This form represents the original and predominant method of cigarette smoking, distinguishing it from non-combustible alternatives like electronic cigarettes or heated products that avoid burning the . The basic structure includes a rod, wrapping , and often a filter at the mouthpiece end, designed to deliver and other compounds via inhaled . Standard dimensions for these cigarettes vary by market but commonly include lengths of 70 mm for regular size and 84 mm for king size, with diameters of 7.5 to 8.0 mm. Packs typically contain 20 cigarettes, housed in boxes measuring approximately 85 mm x 55 mm x 20 mm to accommodate these sizes. A standard pack of 20 cigarettes thus provides approximately 200 to 300 puffs, based on typical smoking behavior of 10 to 15 puffs per cigarette. Unlike slim variants with reduced diameters of 5-6 mm or extended 100 mm and 120 mm lengths, traditional models adhere to these conventional specifications without structural modifications for altered smoke yield. The tobacco blend is primarily combustive, generating over 6,000 chemicals upon burning, many toxic, in contrast to vaporization methods in newer products. These cigarettes are mass-produced and widely available, forming the core of global use despite shifts toward alternatives, with combustible products accessible to nearly all adult populations worldwide. Their design prioritizes efficient for , without the flavorings, ventilation, or reduced-tar seen in specialty variants developed post-1950s in response to concerns. Empirical indicate that traditional combustibles deliver variable exposure mimicking historical patterns, though exact yields depend on puffing behavior and composition.

Low-Yield and Filtered Variants

Cigarette filters, typically composed of cellulose acetate tow, were introduced in the early but gained widespread adoption in the amid rising concerns over , as manufacturers shifted from unfiltered to filtered designs to mitigate perceived risks. These filters aimed to trap particulate matter, reducing machine-measured yields by 40-50% compared to unfiltered cigarettes. By the late , filtered cigarettes dominated the market, comprising over 80% of U.S. sales by 1960, promoted as a technological advancement for cleaner smoke delivery. Low-yield variants, often labeled "light," "ultra-light," or low-tar/low-nicotine, emerged in the and proliferated through the , featuring innovations like filter ventilation—small perforations allowing dilution of smoke with air to lower (FTC) machine-tested yields to under 15 mg tar and 1 mg per cigarette. These designs used expanded or reconstituted blends to further minimize nominal deliveries, capturing significant ; by 1976, low-tar options accounted for about 15% of sales, rising rapidly thereafter. Manufacturers marketed them as reduced-harm products, with emphasizing engineering for "smoother" and implied benefits. However, empirical evidence indicates these variants do not substantially lower health risks, as smokers engage in compensatory behaviors to maintain nicotine intake, including deeper inhalation, more frequent puffs, increased cigarette consumption, and manual occlusion of ventilation holes. Studies measuring biomarkers like cotinine and exhaled carbon monoxide show that actual toxin exposure from low-yield cigarettes approximates that of regular variants, negating machine-yield reductions. For instance, a National Cancer Institute analysis concluded that light cigarettes provide no risk attenuation for lung cancer or other smoking-related diseases, attributing this to unaltered carcinogen uptake despite design changes. Epidemiological data reinforce this, with cohort studies finding no significant difference in , COPD, or incidence between low-yield and full-flavor smokers after adjusting for total consumption and confounding factors. Partial compensation occurs in roughly 50-70% of cases, per reviews of , but full equivalence in exposure is common due to nicotine's reinforcing driving behavioral adaptation. Consequently, low-yield and filtered variants have been critiqued as deceptive innovations that prolong without causal risk mitigation, prompting regulatory bans on yield-based descriptors in the U.S. by 2010.

Flavored, Slim, and Specialty Cigarettes

Flavored cigarettes incorporate non-tobacco additives to impart distinct tastes, such as , which provides a cooling sensation, or previously fruit and candy profiles. In the United States, the Family Smoking Prevention and Tobacco Control Act of 2009 banned characterizing flavors in combustible cigarettes except for menthol and tobacco, effective September 22, 2009, aiming to curb youth initiation by reducing appeal. cigarettes, which mask smoke harshness and facilitate deeper , accounted for over 40% of adult smokers in 2020, with prevalence rising among racial/ethnic minorities, youth, and females. Empirical data indicate menthol use correlates with higher initiation rates and lower cessation success in some cohorts, though direct causation remains debated; studies find no elevated cancer risk compared to non-menthol variants. Regulatory efforts, including FDA proposals in 2022 to eliminate cigarettes, face opposition citing potential growth and negligible gains, as flavor bans in other jurisdictions have redirected consumption to unflavored or alternative products without reducing overall use. Slim cigarettes differ from standard variants by having a narrower , typically 5.4 to 6 millimeters versus 7.5 to 8 millimeters for conventional king-size, often with increased length to sustain similar puff volumes and yields. Introduced prominently with brands like in 1968, they were marketed to women emphasizing slenderness, , and , associating the product with feminine and lighter experiences. Market share has expanded in regions like , appealing to younger demographics through sleek packaging and perceptions of reduced harm, despite evidence showing equivalent , , and health risks to regular cigarettes. Studies confirm slims deliver no meaningful dose reduction, as smokers compensate via adjusted , underscoring marketing-driven illusions over empirical safety differences. Specialty cigarettes encompass non-standard combustible tobacco products like kreteks and bidis, which deviate from conventional blends in composition and cultural origins. Kreteks, originating from , blend with 30-40% ground s, imparting a spicy flavor and higher tar levels due to clove oils; U.S. imports peaked in the 1990s before FDA classification as drug-device hybrids in 2009 restricted marketing claims. Bidis, hand-rolled in using tendu leaf wrappers and minimal , require stronger draws for , yielding 3-5 times higher tar and than U.S. cigarettes; they gained U.S. traction in the 1990s among youth for exotic appeal but carry elevated risks of and from unfiltered, tightly drawn smoke. Other specialties include additive-free "natural" cigarettes like American Spirits, promoted for purer but lacking evidence of , as byproducts remain inherent to burning material. These variants often evade standard regulations through status or niche positioning, though prevalence remains low compared to mass-market types.

Non-Combustible and Harm-Reduction Alternatives

Non-combustible alternatives to combustible cigarettes include electronic nicotine delivery systems (ENDS), heated tobacco products (HTPs), and oral nicotine products such as and nicotine pouches, which deliver without burning and thus limit exposure to combustion-generated toxins like tar, polycyclic aromatic hydrocarbons, and . These products emerged prominently in the , with ENDS sales surpassing traditional cigarettes in some markets by 2023, driven by their appeal as lower-risk options for nicotine maintenance. from biomarker studies shows switching from cigarettes reduces levels of harmful constituents, supporting for persistent users, though absolute risks persist due to nicotine's addictive properties and other constituents. Electronic cigarettes aerosolize , vegetable glycerin, , and flavorings via battery-powered heating elements, avoiding . Randomized trials demonstrate ENDS achieve higher smoking abstinence rates than (NRT) or behavioral support alone, with one reporting a risk ratio of 1.63 for quitting at six months. Toxicological assessments confirm ENDS aerosols contain 90-95% fewer harmful chemicals than cigarette , correlating with lower and in cellular models. Population studies indicate reduced odds of cardiovascular events among exclusive vapers versus smokers, though dual use with cigarettes attenuates benefits and may elevate relapse risk. Independent reviews highlight aerosol risks, including aldehydes from overheating and potential metal leaching, but emphasize net for smokers switching completely. Heated tobacco products like Philip Morris's heat tobacco sticks to 350°C, releasing nicotine vapor with minimal . Chemical analyses reveal HTP emissions with substantially lower yields of 72 measured toxicants compared to cigarettes, including reduced and volatile organics. Short-term switching trials report decreased urinary biomarkers of exposure, such as NNAL (a tobacco-specific ), by over 90% after five days. Respiratory cohort data show modest declines in susceptibility post-switch, though endothelial function improvements lag behind complete cessation. Critiques note residual harmful emissions, including irritants at levels sufficient for acute vascular effects, underscoring HTPs as incremental rather than complete risk eliminators. Smokeless oral products bypass inhalation risks; Swedish snus, a pasteurized tobacco pouch, correlates with lung cancer rates 1-2% of smokers' in long-term Swedish cohorts, attributing causality to absent combustion carcinogens. Nicotine pouches, tobacco-free variants with synthetic or extracted nicotine, exhibit lower in vitro toxicity than snus or cigarettes, with pharmacokinetic studies confirming rapid nicotine delivery comparable to smoking for craving suppression. Clinical trials of pouch substitution reduce cigarette consumption by 50-70%, with minimal impact on cardiovascular biomarkers like blood pressure in short-term use. Oral products carry oral mucosa irritation and nicotine dependence risks, with American Heart Association reviews citing potential for elevated heart rate but absent smoke-related endothelial damage. Overall, these alternatives substantiate harm reduction via reduced toxin profiles, though optimal outcomes require exclusive use and long-term data remain nascent as of 2025.

Pharmacology and Immediate Effects

Nicotine as the Primary Psychoactive Agent

Nicotine, a naturally occurring alkaloid comprising 0.6–3.0% of the dry weight of tobacco leaves, serves as the principal psychoactive compound responsible for the rewarding and addictive properties of cigarette smoking. Upon inhalation of tobacco smoke, nicotine is rapidly absorbed through the alveolar membranes of the lungs, achieving peak plasma concentrations within 5–10 seconds and crossing the blood-brain barrier to elicit central nervous system effects almost immediately. This pharmacokinetic profile—far quicker than oral or transdermal routes—underpins the reinforcement of smoking behavior, as the swift delivery mimics intravenous administration and sustains habitual use. As a agonist, binds primarily to α4β2 subtypes in the , triggering the release of neurotransmitters including in the , which generates sensations of pleasure, arousal, and reduced anxiety. These effects, observed consistently in human and , drive the subjective "buzz" reported by smokers and contribute to the development of , with tolerance emerging through receptor upregulation and desensitization over repeated exposure. Withdrawal from manifests as irritability, anxiety, and cognitive deficits, further entrenching as users smoke to alleviate these symptoms rather than solely for initial . Empirical data from imaging confirm that 's modulation of activity correlates directly with self-reported craving intensity in abstinent smokers. While cigarette smoke contains over 7,000 chemicals, including inhibitors that may potentiate 's effects, remains the dominant agent for psychoactivity, as evidenced by the comparable profiles of pure delivery systems like patches or gums, albeit without the rapid onset of . Laboratory studies isolating from tobacco particulates demonstrate its independent capacity to enhance attention and mood, underscoring that byproducts primarily confer rather than primary . This causal primacy holds despite historical debates, with longitudinal cohort linking yield variations in cigarettes to adjusted rates among users.

Combustion Byproducts and Acute Physiological Responses

Cigarette combustion at temperatures between 600–900°C generates mainstream smoke comprising particulate matter (tar) and gaseous phase components, yielding over 7,000 distinct chemical compounds, including more than 80 identified carcinogens such as benzene, formaldehyde, polycyclic aromatic hydrocarbons (PAHs), and tobacco-specific nitrosamines (TSNAs). Carbon monoxide (CO) constitutes a major gaseous byproduct, with each cigarette delivering 10–20 mg, elevating carboxyhemoglobin (COHb) levels in smokers from baseline values of approximately 4.2% to 8.6% post-smoking, thereby impairing hemoglobin's oxygen-binding capacity and reducing tissue oxygenation. Hydrogen cyanide and other cyanogenic compounds further contribute to acute toxicity by inhibiting cellular respiration, while nicotine, absorbed rapidly via inhalation (yielding peak plasma levels within 5–10 minutes), acts as the primary alkaloid driving immediate pharmacological responses. Upon inhalation, these byproducts elicit acute cardiovascular responses, including activation from , which elevates by 10–15 beats per minute, increases systolic by 5–10 mmHg, and promotes adrenaline release, enhancing and . CO's interference with oxygen delivery exacerbates myocardial oxygen demand-supply mismatch, potentially precipitating ischemia in vulnerable individuals, while particulate matter and irritants trigger bronchial constriction and disruption within seconds to minutes. Respiratory effects manifest as immediate increases in and , attributable to aldehydes and irritating mucosal linings. Central nervous system responses include nicotine-induced dopamine release in reward pathways, fostering acute reinforcement and alertness, alongside mild anxiolytic effects at low doses, though higher exposures can induce nausea via peripheral chemoreceptor stimulation. Oxidative stress from free radicals in smoke—such as hydroxyl radicals and quinones—prompts rapid endothelial dysfunction, measurable as reduced flow-mediated dilation within 30 minutes, and elevates markers of lipid peroxidation. These responses vary by inhalation depth and puff volume, with deep drags maximizing systemic delivery of CO and nicotine, thus amplifying hemodynamic shifts. Empirical studies confirm these effects resolve within 30–60 minutes post-cigarette but recur with subsequent use, contributing to cumulative physiological strain.

Health Effects on Users

Long-Term Empirical Risks from Smoking

Smoking cigarettes over extended periods demonstrably elevates the incidence of chronic diseases, with cohort studies consistently showing dose-dependent increases in mortality risk proportional to pack-years consumed. Large-scale epidemiological analyses attribute roughly 480,000 annual deaths to direct and indirect effects of smoking, encompassing primary causes such as , (COPD), and (CVD). Globally, the estimates over 8 million -related deaths yearly, with more than 7 million stemming from direct use. These figures derive from population-attributable fraction models applied to vital statistics and data from prospective cohorts, though some independent recalibrations suggest modestly lower first-hand estimates around 420,000 U.S. deaths for recent periods, highlighting potential overattribution in official tallies due to modeling assumptions about never-smoker baselines. Lung cancer represents the paradigmatic long-term risk, with current smokers exhibiting relative risks 15 to 30 times higher than never-smokers across histological subtypes, particularly . Hazard ratios from Norwegian cohort data place the elevated risk at approximately 14-fold for current smokers versus never-smokers, with risks persisting but declining post-cessation in a time-dependent manner. This association holds after adjusting for confounders like age and occupational exposures, supported by biological evidence of polycyclic aromatic hydrocarbons and nitrosamines in smoke inducing DNA adducts and mutations in tissue; quitting reduces incidence by up to 90% after 10-15 years, underscoring over mere . For respiratory diseases, accounts for 80-90% of COPD cases in high-income settings, with ever-smokers showing rates over 17% compared to under 7% in never-smokers. Odds ratios exceed 20 for severe airflow obstruction in older smokers, reflecting cumulative damage from irritants like and oxidants that provoke chronic inflammation, , and small airway remodeling. Empirical dose-response curves confirm progression with intensity and duration, as measured by forced expiratory volume decline in longitudinal studies. Cardiovascular risks manifest earlier, with current smokers facing 2- to 4-fold higher incidence of and versus non-smokers, driven by , promotion, and accelerated from and . Hazard ratios for all-cause CVD mortality approximate 1.4 for current users, escalating to over 4.6-fold in heavy smokers, with benefits of cessation evident within 5 years but residual elevation persisting up to 25 years.
Disease CategoryApproximate Relative Risk (Current vs. Never-Smokers)Key Supporting Evidence
15-30Meta-analyses of cohort studies showing subtype-specific elevations.
COPDOdds ratio >20 (severe cases)Prevalence disparities and spirometric decline in smokers.
2-4 (incidence); HR ~1.4-4.6 (mortality)Prospective follow-up data on events and endothelial mechanisms.
Additional empirical links include elevated risks for other malignancies (e.g., laryngeal, bladder) and non-neoplastic conditions like (relative risk ~1.4) and exacerbations, though these exhibit weaker dose-responses than primary endpoints. Overall life expectancy shortens by 10-15 years for lifelong smokers, with risks varying by , (similar magnitudes but earlier onset in women for some CVD subtypes), and co-exposures.

Dose-Response Relationships and Individual Variability

The dose-response relationship between cigarette and adverse outcomes demonstrates a graded increase in risk with greater exposure, quantified primarily through metrics such as pack-years (cigarettes per day divided by 20, multiplied by years smoked) and cigarettes smoked daily. Large cohort studies, including a 25-year follow-up of over 100,000 U.S. adults, reveal that smokers consuming 30 or more cigarettes per day exhibit a 21% higher total compared to never-smokers (57.7% vs. 36.3% cumulative deaths), with risks escalating nonlinearly for , , and (COPD). Meta-analyses confirm this pattern for , where rises from approximately 1.76 at 5 pack-years to 21.52 at 85.7 pack-years among adults. Similarly, all-cause mortality risks for cancer and cardiovascular events show dose-dependent elevations, with heavier (e.g., >20 cigarettes/day) correlating to relative risks of 1.5–3.0 or higher, independent of cessation timing. While pack-years integrate duration and intensity, evidence indicates that smoking duration exerts a stronger influence on and COPD risk than daily intensity alone, challenging the adequacy of pack-years as a sole predictor. For instance, prolonged exposure (e.g., decades of light ) yields higher absolute risks than shorter bursts of heavy , as cumulative and tar deposition drive more than acute dosing. This duration primacy holds in prospective studies adjusting for confounders like age and comorbidities, though intensity amplifies risks in susceptible tissues like the , where nonlinear dose-responses differ by sex. Quitting mitigates but does not fully erase risks; individuals with >15 quit-years post-20 pack-years retain elevated 5-year risks (up to 2–3% absolute risk in ages 55–74). Individual variability in smoking-related harms arises from genetic, metabolic, and physiological factors that modulate processing, toxin clearance, and disease susceptibility. Variants in the gene, which encodes the primary enzyme for , significantly influence consumption patterns and risk; slow metabolizers (e.g., with reduced-activity alleles) exhibit lower clearance rates, leading to reduced cigarette intake (often <10/day) and 30–50% lower lung cancer odds among smokers compared to normal metabolizers. This interaction stems from slower inactivation prompting less frequent smoking to maintain dependence, thereby limiting carcinogen exposure. Polygenic scores incorporating variants near nicotinic acetylcholine receptor genes (e.g., CHRNA5) further explain 5–10% of variance in heavy smoking (>25 cigarettes/day) and interact with exposure to heighten COPD progression. Sex, age at , and comorbidities introduce additional heterogeneity; women may experience steeper cardiovascular dose-responses due to estrogen-modulated endothelial effects, while early starters (<15 years) face amplified genetic risks from developmental lung immaturity. Genome-wide association studies across diverse ancestries identify thousands of loci linking smoking propensity to cardiovascular and pulmonary outcomes, underscoring that while average risks follow dose gradients, outliers (e.g., heavy smokers with protective detoxification alleles) evade typical harms, though such cases comprise <5% of populations. Empirical data from twin studies affirm heritability estimates of 40–60% for smoking persistence and disease liability, emphasizing causal roles beyond environmental confounders.

Relative Risks Compared to Other Substances and Lifestyles

Regular cigarette smoking elevates all-cause mortality risk by a factor of 2.5 to 3.0 relative to never-smokers, based on cohort studies tracking dose-response effects over decades. This translates to a reduction in life expectancy of 10 to 15 years for persistent smokers, primarily from cardiovascular disease, lung cancer, and chronic obstructive pulmonary disease. In comparison, heavy alcohol consumption (e.g., 5 drinks per day) equates to a similar premature mortality burden as smoking 4 to 5 cigarettes daily for women and slightly more for men, per lifetime risk models integrating epidemiological data. Moderate alcohol intake, however, exhibits a lower relative risk (often <1.2 for all-cause mortality due to potential cardioprotective effects in some populations), though causal attribution remains debated given confounding factors like socioeconomic status. Globally, tobacco use caused approximately 8 million deaths in 2019, surpassing alcohol-attributable deaths at 2.6 million and illicit drug-related deaths at around 500,000, reflecting tobacco's higher prevalence and chronic harm profile despite lower acute lethality per use. Among drugs of misuse, multicriteria analyses rank 's physical harm to users moderately high (score of 26 out of 100 overall harm, driven by long-term organ damage), below (55) and (54) but comparable to alcohol (72 overall, due to acute and societal effects). ranks lower in harm (20-25), with relative mortality risks 1.2 to 1.5 times higher for heavy users versus non-users, lacking tobacco's combustion-related carcinogenicity. Opioids, conversely, impose acute overdose risks with mortality rates exceeding 10 per 1,000 users annually in high-prevalence cohorts, far outpacing tobacco's per-user fatality rate of 1 in 2 lifetime for long-term smokers.
Risk FactorApproximate Life Expectancy Reduction (Years)Primary Mechanism
Pack-a-day smoking10-15Chronic inflammation, carcinogenesis from combustion byproducts
Severe obesity (BMI >35)8-13, cardiovascular strain
Physical inactivity3-5Reduced cardiovascular reserve,
Heavy alcohol use (>4 drinks/day)5-10Liver , neuropathy; J-shaped for moderate
Compared to factors, 's impact exceeds that of sedentary , which shortens life by 2 to 5 years via diminished , and rivals severe 's 6 to 13-year decrement through compounded metabolic and inflammatory pathways. Combined risks amplify effects; for instance, plus or inactivity can compound mortality hazards beyond additive models, as seen in cohorts where clustered behaviors account for over 50% of premature deaths before age 75. These comparisons underscore tobacco's position as a leading modifiable risk, with empirical data from large-scale registries emphasizing dose-dependent over correlative confounders.

Secondhand Exposure and Broader Impacts

Evidence on Passive Smoking Effects

, also known as environmental tobacco smoke exposure, involves non-smokers inhaling a mixture of sidestream from burning cigarettes and exhaled mainstream from active smokers. Epidemiological studies, primarily case-control and cohort designs, have investigated associations with various health outcomes, though interpretations are complicated by small relative risks, potential confounders like diet and occupation, and via self-reports prone to misclassification. For in never-smokers, multiple meta-analyses report s of approximately 1.20 to 1.30 associated with spousal or workplace exposure, based on pooled data from dozens of studies involving thousands of cases. These estimates imply a 20-30% elevated , but the absolute increase remains minimal given the low baseline incidence of among never-smokers (roughly 1% lifetime risk in high-income countries), translating to an added lifetime absolute on the order of 1 in 1,000 even at the upper end of estimates. Contrasting evidence emerges from large prospective cohorts; a 2003 analysis by Enstrom and Kabat of the American Cancer Society's Study I cohort (118,094 California adults followed from 1959 to 1998) found no significant association between spousal smoking and mortality, with an overall of 0.94 (95% CI 0.85-1.04) after adjusting for age, race, and other factors. This study, covering 39 years and over 10,000 -related deaths, highlighted null or protective associations in subgroups, challenging claims despite criticisms regarding initial partial industry funding (disclosed and not applicable to the reanalysis). Evidence for similarly shows meta-analytic relative risks of 1.25 to 1.30 for coronary heart disease in exposed non-smokers, drawn from cohort and case-control . These modest associations are biologically plausible given sidestream smoke's irritant and thrombogenic components at acute high exposures, but chronic low-level effects lack robust dose-response gradients, and confounders such as shared lifestyle factors may inflate estimates. The Enstrom and Kabat cohort reported no elevated mortality risk for heart disease from spousal exposure ( 0.98, 95% CI 0.94-1.02), aligning with critiques that small relative risks in observational often fail to establish causation amid residual biases. In children, passive smoking correlates with increased incidence of lower respiratory tract infections, , and exacerbations, with meta-analyses indicating odds ratios of 1.5 to 2.0 for these acute outcomes, supported by stronger evidence from controlled settings showing immediate airway . Absolute risks, however, are context-dependent and diminish with reduced exposure levels; for instance, sudden infant death syndrome risk rises by about 2-fold with maternal smoking during pregnancy or postnatal household exposure, but this encompasses confounding prenatal effects. Overall, while short-term irritant effects are empirically clear, long-term disease causation in adults hinges on associative with inherent limitations, prompting ongoing over the proportionality of responses to the quantified risks.

Methodological Debates in Epidemiological Studies

Epidemiological studies on (SHS), also known as environmental tobacco smoke (ETS), have relied heavily on observational designs such as case-control and cohort studies due to ethical barriers to randomized controlled trials. Case-control studies, which compare exposure histories between cases and controls, have been criticized for , where nonsmoking cases may over-report spousal smoking to explain their illness, inflating odds ratios typically reported as 1.2 to 1.3 for risk. factors, including dietary habits, , and occupational exposures, are difficult to fully adjust for in these designs, potentially attributing unrelated risks to SHS. Prospective cohort studies, such as the American Cancer Society's Study I (CPS-I) and II (CPS-II), offer stronger evidence by assessing exposure before outcomes occur, but they face challenges in exposure misclassification from self-reported data without biomarkers like levels, which correlate poorly with long-term ETS effects. A 2003 reanalysis of CPS-I data by Enstrom and Kabat, tracking over 118,000 adults from 1960 to 1998, found no statistically significant association between spousal smoking and ( 0.75, 95% CI 0.42-1.35) or coronary heart disease mortality after adjusting for age, education, and other factors, concluding the data do not support a causal link though a small effect remains possible. This study highlighted low statistical power for detecting small risks in low-exposure settings, where absolute incidence among never-smokers is under 20 per 100,000 annually, making even 20-30% relative increases yield few attributable cases. Critics of the Enstrom-Kabat findings argued methodological flaws, including reliance on historical exposure assumptions and partial funding from the Center for Indoor Air Research (a tobacco-linked entity), though the authors maintained data transparency and pre-existing access to CPS-I records. Broader debates question the absence of a clear dose-response relationship in many cohorts, where risks do not consistently rise with reported exposure intensity or duration, challenging Bradford Hill causality criteria. Institutional biases in , including advocacy funded by governments and NGOs, have led to selective emphasis on positive associations while dismissing null results as industry-influenced, despite similar critiques applying to pro-SHS-harm studies from WHO-affiliated groups. Recent meta-analyses of ETS and non-lung cancers report weak or null associations, underscoring persistent uncertainties in extrapolating from active risks, which involve 4000-fold higher doses. A reappraisal of CPS-II data similarly found negligible mortality risks from spousal ETS (hazard ratio near 1.0), attributing prior overestimations to unadjusted confounders rather than causation. These debates emphasize the need for improved biomarkers and longitudinal designs to disentangle SHS from correlated factors, with suggesting any causal effect, if present, is smaller than commonly portrayed in policy-driven summaries.

Comparisons to Other Environmental Exposures

exposure elevates the of in never-smokers by approximately 20-30%, based on meta-analyses of spousal and workplace exposure studies. This corresponds to an estimated 7,300 attributable deaths annually among U.S. nonsmokers. In comparison, residential exposure, the second leading cause of overall, is estimated to cause around 21,000 U.S. deaths per year, with synergistic effects amplifying risks in smokers but still significant for never-smokers (approximately 2,100-2,900 attributable cases). 's excess is about 15% per 100 /m³ increment for never-smokers, yielding population-level risks comparable to or exceeding those from at typical indoor concentrations (around 40 /m³ average). Ambient fine particulate matter (PM2.5) from presents another environmental exposure with associations in never-smokers, with meta-estimated relative risks of about 1.10 per unspecified increment in exposure, though long-term average exposures of 10-20 μg/m³ correlate with risks in the 10-40% range across cohorts. Globally, PM2.5 contributes to over 200,000 deaths yearly, positioning it as the second leading cause after active , with effects synergistic to use but independently causal at environmental levels. particles, a key PM2.5 component, carry Group 1 status from the International Agency for Research on Cancer, yet their relative risks for in non-occupational settings mirror secondhand smoke's modest elevations (around 20-40% for high-exposure nonsmokers). Other indoor pollutants, such as those from in poorly ventilated spaces, impose higher acute respiratory burdens in developing regions, with odds ratios for and exceeding 2.0 in exposed never-smokers—substantially larger than secondhand smoke's effects. fibers from environmental sources (e.g., natural deposits or deteriorating building materials) confer low-level risks in the general , with relative risks below 1.1 for non-occupational exposure, far lower than occupational levels but still contributory to cases. Epidemiological challenges persist across these exposures: small relative risks (typically 1.1-1.3) invite by unmeasured factors like diet, genetics, or residual active , and publication biases in academia—often aligned with regulatory agendas—may inflate secondhand smoke estimates relative to or PM2.5, where mechanistic evidence (e.g., damage from ) bolsters causal claims independently of .
ExposureApproximate RR for Lung Cancer in Never-SmokersKey Source of Data
Secondhand Smoke1.20-1.30Meta-analyses of cohort studies
Radon (per 100 Bq/m³)1.15Pooled residential exposure data
PM2.5 (incremental)~1.10Global meta-estimates
Diesel Exhaust (environmental)1.20-1.40Occupational/non-occupational cohorts
These comparisons underscore that while is causally linked to via over 60 known carcinogens, its population impact among never-smokers is on par with or modestly below and urban , prompting scrutiny of disproportionate policy emphasis given equivalent uncertainties in low-dose extrapolations.

Consumption Patterns and Epidemiology

As of 2024, an estimated 20% of adults aged 15 years and older—approximately 1.25 billion people—used products worldwide, with cigarettes comprising the predominant form among smokers. This represents a decline from about 33% in 2000, driven by interventions, though absolute user numbers remain elevated due to . Regional variations are stark, with the WHO European exhibiting the highest at 24.1% in 2024, surpassing , where rates have historically been elevated but are now lower on average. In contrast, the Americas and Western Pacific regions report lower averages, around 15-17%, reflecting stronger implementation of measures in higher-income settings. Demographic disparities underscore gender imbalances, with males accounting for roughly 80% of global ; in 2019, approximately 940 million adult males and 193 million females were current cigarette . This gap persists across regions, particularly in South and , where male often exceeds 40% while female rates remain below 5%, influenced by cultural norms restricting women's use. Age patterns show initiation typically occurring in or early adulthood, with peak in the 25-44 age group globally, though daily rates decline after age 55 due to cessation, mortality, or interventions. In low- and middle-income countries, which host over 80% of users, correlates inversely with , higher among lower-income and less-educated populations.
Demographic FactorKey Trends (Global, Recent Data)
GenderMales: ~36% prevalence; Females: ~8%; Male-to-female ratio ~5:1 in many developing regions.
AgeHighest in 25-44 years (~25-30%); Lowest in 65+ (~10-15%) and youth 15-24 (~15%, but rising initiation risks).
Region (WHO)Europe: 24.1%; Southeast Asia: ~20-25% (male-dominated); Africa: ~10-15% (growing in urban youth).
Income LevelLow/middle-income: 25%+; High-income: <15%, with faster declines via policy enforcement.
Projections indicate a continued but uneven downward trajectory, with global prevalence potentially falling to 15% by 2030 if current trends hold, though stagnation in regions like the and parts of may hinder progress due to weak and industry . These patterns reflect causal drivers such as affordability, advertising bans, and taxation efficacy, rather than uniform behavioral shifts.

Recent Declines and Shifts (2000-2025)

Global prevalence of cigarette smoking among adults aged 15 years and older declined from 27% in 2000 to an estimated 16% in 2022, with projections indicating further reduction to around 15% by 2025. This equates to a drop in the absolute number of users from 1.38 billion in 2000 to 1.2 billion in 2024, driven primarily by reduced cigarette consumption in high- and middle-income countries. Global cigarette stick sales volume decreased by 11.6% between 2008 and 2022, with steeper declines in the (40.6%) and (35.4%), though consumption in low-income regions like parts of and has plateaued or grown more slowly due to population increases offsetting reductions. In the United States, adult cigarette prevalence fell from 23.3% in 2000 to 11.6% in 2022, representing a 50% relative decline and affecting approximately 28.8 million current smokers in the latter year. Among young adults aged 18-24, the odds of current decreased by one-third between 2000 and 2010, with continued reductions through 2019 amid heightened anti- campaigns and regulations. Similar trends appear in and other high-income areas, where prevalence among men dropped 27.2% and among women 37.9% since 1990, accelerating post-2000 due to indoor bans, taxation, and cessation programs. A key shift has been the rise of alternative nicotine products, particularly electronic nicotine delivery systems (ENDS or e-cigarettes), which gained prominence after 2010. U.S. exclusive cigarette smoking decreased by 6.8 million adults between 2017 and 2023, while e-cigarette use rose, with current adult ENDS prevalence reaching 6.0% by recent estimates—partially offsetting overall tobacco decline but substituting for combustible cigarettes in many cases. Heated tobacco products and smokeless options have also captured market share in regions like Japan and parts of Europe, contributing to cigarette volume erosion despite stable or growing overall nicotine consumption. These transitions reflect causal factors including perceived harm reduction, flavor appeal to youth, and industry pivots, though long-term health impacts remain under empirical scrutiny.

Factors Influencing Usage Rates

strongly correlates with cigarette usage rates, with lower income, , and occupational prestige consistently linked to higher prevalence across demographics. In the United States, low was associated with elevated smoking rates among adults, irrespective of age, race/, or , as evidenced by analyses of surveys. Globally, tobacco use prevalence is disproportionately higher among those with lower levels, manual occupations, and reduced , particularly in low- and middle-income countries where men in rural areas exhibit the highest rates. These patterns persist into recent years, with financial strain mediating the relationship between low socioeconomic position and both and intensity of . Price sensitivity, driven primarily by excise taxes, exerts a causal downward pressure on consumption volumes. Empirical estimates indicate that a 10% increase in cigarette prices reduces overall usage by 3% to 5%, with youth consumption declining by about 7% due to heightened elasticity among younger smokers. Regulations such as public smoking bans further suppress demand by increasing perceived inconvenience and social costs, complementing tax effects in econometric models of consumption behavior. Advertising restrictions have contributed to reduced initiation, though direct impacts on aggregate consumption remain debated, with U.S. industry expenditures shifting from traditional ads (down to under 3% of marketing by 2019) toward promotions that partially offset price hikes. Social and environmental influences, including and peer networks, predict and persistence, often overriding individual risk perceptions in . with smoking parents or friends face elevated odds of experimental and regular use, as and normalize exposure. Demographic trends show higher male , with uptake concentrated before age 25; those not smoking regularly by then rarely start later. Recent global declines from 1.38 billion users in 2000 to 1.2 billion in 2024 reflect strengthened anti-smoking campaigns and norms, though vulnerabilities persist in lower socioeconomic groups amid the era. In the U.S., adult fell 17% from 2018 to 2022, driven by cohort effects where those over age 27 in 2020 exhibited lower probabilities of use compared to prior generations.

Economic Dimensions

Tobacco Industry Structure and Global Trade

The tobacco industry exhibits an oligopolistic structure, dominated by a handful of multinational corporations and state-owned enterprises that control the majority of global production, processing, and distribution of tobacco products, particularly cigarettes. The five leading entities—China National Tobacco Corporation (CNTC), , , , and —account for the bulk of worldwide output and sales, with cigarettes comprising approximately 82% of the market segment in 2024. CNTC, as 's , produces over 40% of global cigarettes but primarily serves domestic consumption, limiting its export role while exerting influence through international joint ventures. In contrast, , , and operate as vertically integrated multinationals, managing cultivation, , and across multiple countries, often adapting to local regulations and consumer preferences to maintain market shares exceeding 15-20% each in key regions outside . State monopolies persist in select nations, such as and historically in others like before partial , enabling governments to capture revenues while insulating operations from full competitive pressures; however, in countries like and has invited foreign investment, fostering hybrid models where multinationals partner with local entities. This concentration facilitates in leaf sourcing from major growers—, , and the —and in , where facilities in low-cost regions process flue-cured and burley varieties for export-oriented brands. Illicit trade, estimated at 10-15% of global volume, undermines formal structures by bypassing taxes and regulations, though multinationals invest in anti-counterfeiting technologies amid ongoing disputes with regulators over allegations. Global production reached approximately 6.4 million metric tons in 2023, with projections for a decline to 6.3 million tons by 2028 due to shrinking and regulatory constraints on farming. in tobacco products, valued at $52.09 billion in exports for 2024—a decrease from $54.99 billion in 2023—primarily involves unmanufactured leaf and finished cigarettes, with cigarettes as the leading exported category growing at a 3% compound annual rate prior to recent softening. Major exporters include and the for raw leaf, shipping millions of kilograms annually to processors in and , while finished goods flow from multinationals' hubs in (PMI) and the () to high-consumption markets in and . Import dependence in consumer nations like and the sustains this flow, though escalating tariffs and WHO Framework Convention adherence have curbed volumes in developed economies, redirecting trade toward emerging markets where demand sustains industry revenues. The overall market, encompassing production to retail, was estimated at $886.09 billion in 2023, underscoring trade's role in balancing surplus production against localized consumption patterns.

Employment, Revenue, and Fiscal Contributions

The tobacco industry supports employment across agriculture, manufacturing, distribution, and retail, with the majority of jobs concentrated in tobacco farming in developing countries such as China, India, and Brazil, where leaf production drives rural economies. Globally, precise employment figures are challenging to aggregate due to informal labor and varying definitions, but manufacturing remains a smaller segment; in the United States, cigarette and tobacco manufacturing employed 11,101 workers in 2024, reflecting a decline amid automation and regulatory pressures. These roles often provide livelihoods in regions with limited alternatives, though critics from public health organizations contend that economic diversification could yield more sustainable job growth without health externalities. Industry revenue derives primarily from cigarette sales, which dominate the combustible segment. The global market reached USD 886.09 billion in 2023, projected to grow to USD 905.57 billion in 2024, driven by persistent demand in emerging markets despite declines in high-income countries. Leading firms like generated USD 35.7 billion in net sales in 2023, with deriving 80% of its revenue from combustibles in 2024. Revenue streams benefit from pricing power, though offset by illicit trade and shifting consumer preferences toward alternatives like e-cigarettes. Fiscal contributions from primarily stem from taxes, which governments leverage for while aiming to consumption. Worldwide, annual tobacco tax collections approach USD 1 , supporting public budgets in both developed and developing nations. In , from 66.2 billion taxed cigarettes rose 3.5% in 2024 compared to the prior year. states collected taxes averaging USD 1.93 per pack in 2024, varying from USD 5.35 in New York to lower rates elsewhere, funding programs beyond health initiatives. These inflows represent a direct fiscal benefit, though empirical assessments of net economic impact, accounting for enforcement costs and , vary by and source perspective.

Taxation Policies and Their Incentives

Cigarette taxation primarily consists of excise duties imposed by governments to generate revenue and discourage consumption through elevated prices, functioning as a "sin tax" that internalizes perceived externalities of smoking. In the United States, federal excise taxes on cigarettes were first enacted in 1862 for wartime revenue, with the current rate set at $1.01 per pack of 20 since April 1, 2009, while state taxes vary significantly, ranging from $0.17 in Missouri to $5.35 in New York as of 2025. In the European Union, minimum excise requirements mandate at least €1.80 ($2.12) per pack plus 60% of the retail price, with countries like the United Kingdom imposing effective rates exceeding €12 per pack through combined specific and ad valorem components. Globally, the World Health Organization advocates for taxes comprising at least 70% of retail price to maximize health impacts, though implementation differs, with high-tax nations like Australia achieving packs costing over AUD 40 ($26 USD) via annual indexation. These policies create incentives aligned with objectives by leveraging the downward-sloping for cigarettes, where empirical studies demonstrate that increases reduce , particularly among and low-income groups. A of demand elasticities estimates an average elasticity of -0.5, indicating a 10% hike correlates with a 5% drop in consumption, with elasticities up to three times higher at -1.0 to -1.5, prompting greater sensitivity to affordability. Longitudinal U.S. from 2001-2015 link state hikes to declines, with a $1 increase associated with an 8% reduction in adult participation when imposed during . For governments, incentives include substantial fiscal returns—U.S. federal excises yielded $14 billion in 2014 before declining to $9 billion by due to falling consumption—often earmarked for programs, though peaks follow the dynamics where excessive rates diminish net gains. However, high taxes incentivize evasion through and , undermining revenue and health goals by sustaining cheap, unregulated supply. In the U.S., interstate smuggling cost states $4.7 billion in 2022, with high-tax jurisdictions like New York experiencing net inflows of contraband equivalent to 57% of legal sales, while low-tax states like supply outflows. Cross-border dynamics amplify this in , where tax differentials exceeding 500% between nations foster , with illicit cigarettes comprising up to 11% of the EU market and evading health warnings or quality controls. confirms tax gradients predict smuggling rates, though overall consumption still falls as evaders often quit or switch products rather than fully substitute illicit for legal use. This tension highlights causal trade-offs: while taxes causally reduce initiation and prevalence via price signals—supported by difference-in-differences analyses of tax hikes—excessive differentials erode fiscal incentives and may exacerbate criminal economies without proportional health gains.

Cultural and Social Roles

Historical Significance in Rituals and Society

, the primary component of cigarettes, originated in the where cultivated it as early as 6000 BC and integrated it into spiritual practices. Native American tribes viewed as a sacred plant used in ceremonies to communicate with spiritual entities, offer prayers, and facilitate rituals, often smoked in or burned as . In Indian traditions, served as a unifying element in religious observances, symbolizing the connection between humans and higher powers. Among Mesoamerican civilizations, such as the Maya and , held profound ritual importance dating back over a millennium. Mayan priests smoked during ceremonies to invoke deities, with archaeological evidence from residues in vessels confirming its use as early as 700 AD, including infusions for sacrificial and healing rites. In Aztec feasts, was distributed via formalized rituals using elongated tubes, underscoring its role in social and religious gatherings. These practices positioned not as a casual but as a medium for purification, , and offerings to the underworld or gods. Following Christopher Columbus's encounter with tobacco in in 1492, its introduction to transformed it from a ritual staple to a burgeoning social custom. Initially perceived as a medicinal herb, spread through trade and exploration, evolving into pipes and cigars before the cigarette's emergence in the as a convenient, mass-produced form. In European society, smoking became embedded in daily interactions, military traditions, and leisure by the , with cigarettes gaining prominence around 1870 for their portability and ritualistic appeal in social settings like post-meal indulgences or communal gatherings. This shift reflected tobacco's adaptation from indigenous shamanism to a secular of and camaraderie, influencing global cultural norms until health concerns prompted reevaluation.

Portrayals in Media, Literature, and Advertising

Cigarette advertising in the early 20th century often emphasized health benefits and social sophistication, with campaigns claiming brands like Camel were preferred by doctors, as in a 1940s slogan stating "More doctors smoke Camels than any other cigarette" based on informal surveys of physicians. Tobacco companies targeted women through themes of emancipation, such as the 1929 Lucky Strike "Torches of Freedom" campaign associating smoking with independence during women's suffrage movements. By the mid-20th century, ads portrayed smoking as a marker of adulthood and pleasure, featuring attractive models in suits or outdoor settings to appeal to youth emulation. Advertising expenditures peaked at $4.6 billion in 1991, equivalent to over $12 million daily, before broadcast bans took effect in the U.S. on January 2, 1971, following legislation signed by President Richard Nixon in April 1970. In film and television, cigarettes have been depicted as symbols of , maturity, and edginess, with on-screen influencing adolescent rates according to longitudinal studies tracking exposure to over 4,000 films. Popular movies from to glamorized among protagonists, rarely showing consequences, a pattern persisting in modern entertainment where imagery rose 82% in top-grossing films from 2019 to 2023. Historical dramas often include props without depicting harms like cancer, contributing to normalized perceptions despite post-1964 reports. Research from the indicates that 90% of smokers begin as teens, with media portrayals correlating to increased trial rates independent of marketing receptivity. Literature frequently employs cigarettes as motifs for introspection, vice, or social ritual, evident in Arthur Conan Doyle's stories where pipe aids deduction, though cigarettes appear in later adaptations. In Erich Maria Remarque's All Quiet on the Western Front (1929), cigarettes serve as currency and comfort amid , symbolizing fleeting relief. Post-World War II novels, such as J.D. Salinger's (1951), use smoking to convey youthful angst and nonconformity, with Caulfield's chain-smoking underscoring alienation. Authors like and integrated use to evoke bohemian lifestyles, mirroring their personal habits amid widespread cultural acceptance before mid-20th-century revelations shifted symbolic weight toward and decline.

Social Norms and Stigma Evolution

In the early , cigarette smoking transitioned from a niche to a broadly socially accepted practice, particularly in Western societies, where it was glamorized through and media portrayals associating it with , , and . By the mid-20th century, smoking prevalence peaked, with 42% of American adults smoking in , reflecting norms that tolerated or encouraged the behavior in public spaces, workplaces, and social gatherings without significant disapproval. Tobacco companies actively shaped these norms by cigarettes as essential accessories for modern life, targeting diverse demographics including women and through campaigns that normalized uptake across social classes. The release of the U.S. General's 1964 report marked a pivotal shift, conclusively linking cigarette smoking to and other diseases, which began eroding public tolerance by disseminating of health risks and prompting initial skepticism toward prior pro-smoking norms. This report, estimating smokers faced a nine- to ten-fold increased risk of compared to non-smokers, catalyzed a gradual change in attitudes, though rates remained high initially as cultural inertia persisted. By the late and into the , emerging data on hazards further fueled disapproval, leading to voluntary restrictions like television ad bans in and the formation of anti-smoking advocacy groups targeting social acceptability. From the onward, anti-tobacco movements intensified stigma by emphasizing smoking's unpleasant —such as , stained teeth, and burned —alongside imperatives, contributing to and public bans that isolated smokers socially. By the 1980s and 1990s, mass media campaigns and litigation against the reinforced perceptions of as irresponsible and deviant, correlating with a decline in U.S. adult rates to around 18% by the . This stigmatization, while effective in reducing initiation and prevalence, has been critiqued for fostering self-stigma among persistent smokers, potentially complicating cessation efforts by heightening rather than providing supportive pathways. In contemporary contexts, smoker stigma manifests as widespread public disapproval, with surveys indicating high perceived stigma levels—such as in where it correlates with socio-demographic factors and personal values—and varies by group, often internalized more acutely among women and minorities. Globally, this evolution reflects a reversal from industry-driven normalization to policy and cultural pressures prioritizing health, though remnants of acceptance persist in certain regions or subcultures where economic ties to cultivation mitigate stigma. Empirical data links intensified stigma to lower youth uptake but highlights potential backlash, including that may deter quit attempts without adequate cessation resources.

Regulation and Policy Evolution

Early Government Promotion and Subsidies

In the early , the government promoted cigarette use among during to enhance soldier morale, alleviate stress, and foster . In , allocated funds specifically to supply cigarettes as part of soldiers' rations, embedding tobacco consumption within federal wartime logistics and marking an explicit endorsement of as a tool for maintaining combat effectiveness. This initiative contributed to rapid increases in per capita cigarette consumption, rising from 54 packs annually in 1900 to higher levels by the war's end, as returning veterans normalized the habit in civilian society. During , such promotion intensified, with cigarettes included as a standard component of K-rations distributed to troops, justified by military officials for calming nerves, suppressing appetite, and promoting alertness amid combat demands. Over 90 percent of U.S. soldiers smoked by 1945, supported by government-facilitated shipments from tobacco companies, while President personally endorsed the practice, reinforcing its perceived benefits for discipline and psychological resilience. Similar encouragements occurred in other Allied nations, where governments viewed tobacco as essential for troop welfare, though notably pursued anti-smoking policies in contrast. Complementing military efforts, the U.S. extended economic subsidies to tobacco production via the of 1933, classifying tobacco as a "basic commodity" eligible for price supports, production quotas, and supply management to counteract Depression-era market instability. These programs stabilized farming incomes and ensured a steady supply of leaf , the primary raw material for cigarettes, which dominated the industry's output by the mid-20th century. Federal tobacco excise taxes, which accounted for up to one-third of domestic revenue by 1883 and remained substantial thereafter, further incentivized tolerance and indirect support for the sector until health concerns emerged post-1950s.

Shift to Restrictions and Health Warnings (1960s Onward)

In 1962, the Royal College of Physicians in the published the report Smoking and Health, which concluded that smoking causes and contributes to other respiratory diseases, based on epidemiological evidence showing a strong association between cigarette consumption and mortality rates from these conditions. This marked an early institutional acknowledgment of tobacco's health risks, prompting initial discussions on policy responses despite ongoing industry challenges to the causal interpretations. The pivotal shift accelerated in the United States with the 1964 Surgeon General's Advisory Committee report, led by Luther Terry, which analyzed over 7,000 scientific studies and determined that cigarette is causally related to in men, with smokers facing a nine- to ten-fold increased risk compared to non-smokers, and heavy smokers at least a twenty-fold risk; the report also linked smoking to chronic bronchitis, , and . Released on January 11, 1964, this document catalyzed public awareness and policy changes, coinciding with a peak adult smoking prevalence of 42 percent that year. In response, the U.S. passed the Federal Cigarette Labeling and Act in 1965, mandating the warning "Caution: Cigarette Smoking May Be Hazardous to Your Health" on all cigarette packages and advertisements starting January 1, 1966, though it preempted stronger state-level actions and prohibited regulation of advertising content. Building on these developments, the of 1969 banned cigarette on television and radio effective January 2, 1971, following evidence that broadcast promotions had sustained high consumption levels amid emerging health data; this legislation also rotated four stronger warning labels on packs, such as "Warning: The Has Determined That Cigarette Smoking Is Dangerous to Health." Internationally, similar measures followed: introduced package warnings in 1972, while the banned television in 1965 and required health warnings on packets by 1971, reflecting a broader Western policy pivot toward risk disclosure over promotion. These early restrictions laid the groundwork for escalating controls, including indoor smoking prohibitions in public spaces starting in the and , as cohort studies reinforced dose-response relationships between smoking intensity and disease incidence. By the 1980s, warnings evolved to include graphic imagery and specific disease risks in countries like (1984 onward) and (with pictorials by 2001), driven by meta-analyses confirming relative risks exceeding 20-fold for among long-term smokers; however, U.S. labels remained text-only until partial updates in 1984, highlighting regulatory divergences amid industry that emphasized personal choice and disputed absolute causality in some subpopulations. This era's policies correlated with declining per capita consumption—from 4,345 cigarettes annually per adult in the U.S. in 1963 to under 2,000 by 1990—though attribution involves factors like rising taxes and anti-smoking campaigns.

Contemporary Bans, Age Limits, and Enforcement

In the early , comprehensive indoor bans in workplaces, restaurants, bars, and public buildings became widespread globally, driven by concerns over exposure. By 2025, 28 U.S. states and over 1,000 municipalities had enacted strong smoke-free laws covering non-hospitality workplaces, restaurants, and bars, though enforcement varies by jurisdiction. Internationally, countries like extended bans outdoors to beaches, parks, forests, and sports facilities effective July 1, 2025, building on prior indoor restrictions from 2007-2008. Similar policies exist in nations such as , , and the , prohibiting in enclosed public spaces, with partial outdoor extensions in some areas like bus stops. These measures have reduced prevalence in covered venues but face circumvention through designated outdoor areas or private clubs. Product-specific bans have intensified, targeting to curb youth appeal. prohibited sales of flavored tobacco products, including most cigarettes, with full enforcement by December 31, 2025, following earlier restrictions; online sales of such products were banned effective January 1, 2025. As of April 2025, approximately 400 U.S. localities restricted flavored tobacco sales, though federal proposals to ban cigarettes and flavored cigars were withdrawn in January 2025 amid legal and political challenges. In , the Tobacco Products Directive limits certain flavors, but cigarettes remain available pending further reviews. These restrictions have correlated with sales declines in affected areas, such as , where cigarette and e-cigarette volumes dropped post-ban, yet illicit trade and non-compliant retailers persist. Minimum purchase age limits for tobacco products have risen in many jurisdictions to deter youth initiation. In the United States, federal law since December 2019 mandates a minimum age of 21 (Tobacco 21), applying to all products including cigarettes, with states required to align or face enforcement. largely maintains an 18-year threshold, but increased it to 20 effective January 1, 2025, while plans 21 by 2028; proposals for "smoke-free generations" in the UK and aim to phase out sales for future cohorts by annually raising . Globally, ages range from 18 to 21, with some African nations at 19 or 21, though enforcement gaps allow underage access via proxies or online. Enforcement relies on retailer compliance checks, fines, and licensing revocation, but faces persistent challenges including weak verification and circumvention. U.S. sting operations reveal ongoing underage sales despite Tobacco 21, with rates exceeding 10% in some audits, exacerbated by retailer proliferation and online loopholes. Globally, resource constraints limit inspections, fostering black markets; for instance, flavor bans prompt , as seen in California's post-restriction illicit activity. Penalties include fines up to $10,000 per violation in the U.S., yet studies indicate limited impact on overall without broader cultural shifts, as self-reported use declines slower than biomarkers suggest in some analyses.

International Variations and WHO Influence

The (WHO) Framework Convention on Tobacco Control (FCTC), adopted on May 21, 2003, and entering into force on February 27, 2005, serves as the first global public health treaty, ratified by 182 parties covering over 90% of the world's population. The FCTC promotes six key demand-reduction measures under the MPOWER strategy: monitoring tobacco use, protecting from , offering cessation help, warning via packaging and media, enforcing advertising bans, and raising taxes. Its influence has driven national adoptions, with studies showing accelerated implementation of these policies post-ratification, including expanded smoke-free laws in 80% of parties and graphic health warnings in over 120 countries by 2018. However, empirical assessments of its causal impact on smoking prevalence remain mixed; while global tobacco use prevalence fell from an estimated 29.3% in 2000 to 22.3% by 2020, one analysis found no statistically significant acceleration in the pre-existing downward trend in cigarette consumption after 2003. National policies exhibit substantial variations, shaped by FCTC guidelines but adapted to economic, cultural, and political contexts, leading to divergent enforcement levels and outcomes. High-income countries like implemented plain packaging in December 2012, requiring uniform drab packs with large graphic warnings covering 75% of surfaces, which correlated with a 0.9% quarterly drop in prevalence post-introduction. In contrast, enacted a total sales ban on products in 2004, predating full FCTC alignment but reinforced by it, achieving near-elimination of commercial availability though persists. Mexico's 2023 reforms imposed one of the world's strictest regimes, banning in all enclosed public spaces, beaches, and parks, alongside prohibitions on free distribution and visibility restrictions in retail. These measures reflect aggressive FCTC-inspired endgame strategies in low-prevalence nations (under 15%), where five countries—, , , , and the —score highly on FCTC compliance indices.00085-8/fulltext) In developing regions, implementation lags due to tobacco industry lobbying and fiscal dependencies, resulting in more lenient approaches despite FCTC obligations. For instance, , a non-party to the FCTC, maintains minimal restrictions, with still permitted and prevalence at 76.2% among adult males as of 2021, highlighting how non-adoption preserves higher consumption amid weak enforcement elsewhere. , an FCTC party, diverges by promoting heated tobacco products like through tax incentives since 2017, achieving a shift where such alternatives captured 20% of the market by 2020, potentially undermining traditional cigarette declines but aligning with not emphasized in core FCTC provisions. Cross-nationally, 138 countries mandate graphic warnings on packs as of 2024, yet only 42 require plain packaging, illustrating uneven progress.
Country/RegionKey PoliciesSmoking Prevalence (Adults, ~2020)FCTC Ratification
Plain packaging (2012), comprehensive bans11.6%2004
Total sales ban (2004), public use restrictions<1%2004
Nationwide bans including outdoors (2023)13.1%2004
Limited advertising curbs, no plain packs34.5% (overall; 76% males)Non-party
Heated tobacco promotion, indoor bans17.8%2004
These variations underscore FCTC's role in setting minimum standards while allowing sovereignty-driven deviations, with stronger adopters in affluent settings showing greater prevalence reductions, though global impacts are confounded by socioeconomic factors and industry countermeasures.

Environmental Footprint

Agricultural Production Impacts

Tobacco cultivation, primarily of the Nicotiana tabacum plant, requires intensive land preparation and resource inputs, leading to significant environmental degradation in major producing regions such as , , , and parts of . Global tobacco leaf production occupies approximately 5.3 million hectares of annually, often displacing crops and contributing to food insecurity in low-income areas. This land-intensive practice exacerbates ecological strain, with farming activities accounting for a disproportionate share of environmental harm relative to the crop's economic output in many regions. Deforestation is a primary impact, as farmers clear forests for new fields and fuelwood for curing leaves, with an estimated 200,000 hectares of forests and woodlands destroyed yearly worldwide. In developing countries, tobacco-related represents up to 5% of total tree loss, including the felling of around million trees annually to sustain production and . This clearing not only releases stored carbon—contributing nearly 5% of global from agricultural deforestation and curing—but also fragments habitats, reducing and ecosystem services like and water regulation. Soil degradation further compounds these effects, as tobacco's high nutrient demands deplete essential minerals such as nitrogen, phosphorus, and potassium, often leaving fields unproductive after 2-3 seasons and necessitating crop rotation or abandonment. Repeated cultivation increases soil acidity and erosion rates, with studies in regions like Bangladesh and Pakistan documenting micronutrient imbalances and structural breakdown due to monocropping practices. Excessive tillage and harvest expose topsoil to wind and rain, accelerating loss estimated at 20-40 tons per hectare in sloped tobacco fields. Intensive and application amplifies contamination risks, with farming using up to 16 times more pesticides per than staple crops like corn or wheat in some areas. These agrochemicals, including organophosphates and herbicides, leach into and , causing and toxicity to aquatic life, while residues persist in , hindering future agricultural viability. consumption is equally burdensome, depleting over 22 billion cubic meters globally each year for and processing, equivalent to the annual needs of 360 million people, and often polluting sources through runoff.
Impact CategoryKey StatisticPrimary Regions Affected
Deforestation200,000 ha/year cleared, ,
Soil Nutrient DepletionFields unproductive after 2-3 seasons, ,
Pesticide Use16x higher than staples per haGlobal, esp. developing countries
Water Depletion22 billion m³/yearMajor producers worldwide

Manufacturing and Supply Chain Effects

Cigarette encompasses processing, filter production, and high-speed assembly, with global output reaching approximately 6 trillion units annually. leaves undergo curing, stemming, and shredding, followed by blending with additives such as sugars and humectants to enhance flavor and . Filters, comprising tow—a derived from wood pulp and —are formed into rods, while paper and adhesives complete the product via automated machines capable of producing thousands of cigarettes per minute. Energy consumption dominates the environmental footprint of , accounting for at least 60% of impacts due to processes like , cutting, and . In 2014, production of 6 trillion cigarettes required 62.2 petajoules of , equivalent to the annual output of several mid-sized power plants. Major producers like National Tobacco Corporation, responsible for nearly half of global volume, rely heavily on coal-fired , amplifying emissions estimated to contribute substantially to the sector's over 92 million metric tons of annual CO2-equivalent from cultivation through . Water usage in and cleaning further strains resources, though precise factory-level data remains limited by inconsistent industry reporting. The amplifies these effects through extensive logistics, transporting raw tobacco from producers in , , , and the —accounting for over 70% of global leaf supply—to factories worldwide. This involves energy-intensive shipping, trucking, and air freight for perishable components, powered predominantly by fossil fuels and generating additional greenhouse gases. Cellulose acetate production for filters adds upstream impacts, including acetic acid synthesis from and energy for , with life-cycle assessments indicating higher environmental burdens compared to alternative materials due to non-renewable feedstocks. Distribution of finished products to retailers incurs further emissions, though quantified data is sparse, as tobacco firms often underreport in sustainability disclosures scrutinized for greenwashing by outlets like WHO reports.

Waste Management and Litter Realities

Annually, approximately 4.5 trillion cigarette butts are littered worldwide, constituting the most prevalent form of and equivalent to 1.69 billion pounds of . This volume stems from the global consumption of around 6 trillion cigarettes each year, with a significant portion improperly discarded rather than entering formal streams. Cigarette butts account for 30-40% of items collected in international coastal and urban cleanups, highlighting their dominance in marine and terrestrial . Cigarette filters, primarily composed of —a synthetic —do not biodegrade as commonly marketed by the but instead fragment into over time, persisting in the environment for years. These filters trap thousands of chemicals from tobacco smoke, including and , which leach into and bodies upon discard. A single butt can contaminate up to 3.7 liters of with toxins, posing risks to aquatic organisms through direct toxicity and . Recent studies indicate butts also indirectly exacerbate issues by inhibiting beneficial while promoting harmful blooms. Waste management of cigarette remnants remains inadequate globally, with the majority either littered or directed to landfills and incinerators where they contribute to contamination and emissions. initiatives, such as those by in partnership with tobacco companies, process collected butts into products like plastics and asphalt but handle only a negligible fraction due to logistical challenges, contamination, and low participation rates. Economic analyses estimate the from butts and packaging at US$26 billion annually in cleanup and remediation costs, underscoring the inefficiency of current systems. Efforts to develop biodegradable alternatives face hurdles from regulatory requirements and performance standards, limiting widespread adoption.

Controversies and Debates

Industry Manipulation Claims vs. Innovation Defenses

Allegations of manipulation by the center on efforts to conceal health risks and enhance product addictiveness. Internal documents reveal that major manufacturers, including Philip Morris and , understood the link between smoking and by the early 1950s but publicly denied causation through organizations like the Tobacco Industry Research Committee (TIRC), founded in 1954 to sponsor research and foster scientific doubt. The industry manipulated levels by adding compounds like to increase freebase absorption, thereby boosting addictiveness, despite public denials; in 1994, executives from seven companies testified before that was not addictive. These practices were substantiated in U.S. Department of Justice litigation, culminating in court-ordered advertisements in 2017-2018 where companies admitted designing cigarettes to "create and sustain addiction." The 1998 Master Settlement Agreement (MSA) between 46 U.S. states and major tobacco firms mandated release of over 40 million internal pages, exposing tactics such as suppressing unfavorable studies, funding biased research via the Council for Tobacco Research (CTR, successor to TIRC), and marketing to youth despite known risks. Critics, drawing from these archives housed at the University of California San Francisco, argue the industry prioritized profits over public health, with systematic efforts to influence regulators and media; for instance, the industry disseminated data selectively to question secondhand smoke risks identified in the 1970s. Sources amplifying these claims, such as anti-tobacco advocacy groups, often receive MSA funding, potentially incentivizing emphasis on deception, though primary documents provide direct corroboration independent of such biases. In defense, tobacco companies highlight innovations in cigarette design as evidence of harm reduction efforts. Filtered cigarettes, commercialized widely in the —such as Lorillard's brand in 1952 with a filter—aimed to trap and particulates, shifting market dominance from non-filters (0.5% in 1950) to filters (over 80% by the mid-1960s). Ventilation holes in filter tips, introduced in the 1960s and refined through the 1970s, reduced machine-measured and yields, with establishing a dedicated R&D department in the to study product modifications. Industry representatives maintain these changes complied with emerging regulations and reflected genuine investment in safer delivery, denying intentional deception and attributing public skepticism to regulatory overreach rather than fraud. However, empirical studies indicate these innovations yielded limited health benefits due to smoker compensation: individuals inhaled more deeply or smoked more cigarettes to maintain intake, negating reductions and correlating with stable or rising rates despite declining overall levels since the 1950s. The "" and "low-" categories, promoted as healthier, faced lawsuits revealing industry awareness of compensatory , leading to a 2009 U.S. ban on descriptors implying reduced . Defenders counter that such adaptations reflect consumer behavior, not design flaws, and point to R&D expenditures—billions annually by the on prototypes like R.J. Reynolds' heated, non-combusting cigarettes—as proof of proactive evolution amid regulatory pressures. This tension persists, with the industry increasingly pivoting to non-combustible alternatives, though critics view historical cigarette modifications as primarily marketing ploys to sustain sales rather than verifiable mitigation.

Addiction, Autonomy, and Public Health Narratives

Nicotine exerts its addictive effects primarily through activation of neuronal nicotinic acetylcholine receptors (nAChRs) in the , leading to release in reward pathways and of behavior. Dependence prevalence among U.S. adults with past-month cigarette use declined from 59.52% in 2006 to 56.00% in 2019, reflecting both pharmacological compulsion and habitual . However, empirical data indicate nicotine's addictiveness is context-dependent; surveys of substance users found 57% rated quitting cigarettes harder than their primary of , yet this perception correlates with daily cigarette consumption levels rather than inherent pharmacological strength exceeding that of alcohol or . Quitting success underscores limits to the addiction narrative's : among successful long-term quitters (6+ months), the majority—estimated at 64% to 78% in population studies—achieve without formal aids, relying on willpower, environmental changes, or behavioral adjustments. Unassisted attempts comprise over 60% of cessation efforts, with overall success rates around 6 per 100 without aids versus 14 per 100 with alternatives like e-cigarettes, suggesting sustains use but does not preclude autonomous cessation for many. Libertarian perspectives prioritize individual sovereignty, arguing that competent adults retain to assume personal risks from addictive substances, analogous to alcohol or , and that paternalistic restrictions like bans erode volitional freedom without proportionally advancing collective welfare. Public health framing often portrays smoking as an overriding threat to and societal , emphasizing (SHS) risks with claims of widespread carcinogenicity; case-control data show an of 1.30 for among exposed nonsmokers, a modest elevation compared to active smoking's 10-20-fold increase. Critiques highlight narrative amplification, where campaigns induce self-stigma and victim-blaming without commensurate evidence of behavioral impact on high-risk groups, potentially alienating quitters rather than aiding them. Economically, smoking-attributable disease accounts for 5.7% of expenditures and 11.7% of U.S. personal healthcare costs, with smokers' higher per-person spending (up to 40% more at certain ages) offset by taxes and shorter lifespans reducing long-term burdens—facts downplayed in narratives prioritizing externalities over net fiscal contributions. This selective emphasis, rooted in institutional anti-tobacco advocacy, contrasts with causal evidence of declining (e.g., U.S. ever-smoker quit rates rising to 66.5% by 2021) driven by voluntary shifts rather than alone.

Harm Reduction Strategies and Alternative Products

Harm reduction in tobacco use prioritizes reducing exposure to toxicants from cigarette for individuals unable or unwilling to quit entirely, emphasizing substitution with lower-risk delivery methods over continued . Empirical evidence supports that avoiding of smoke from burning substantially lowers disease risks, as generates the majority of carcinogens, , and responsible for smoking-attributable mortality. Strategies include nicotine replacement therapies (NRT) for cessation and non-combustible alternatives like , electronic cigarettes, and heated products for sustained use. Nicotine replacement therapies, including patches, gums, lozenges, and inhalers, deliver controlled nicotine doses without tobacco-derived toxins, doubling the odds of quitting smoking compared to placebo, with success rates rising from about 10% to 17% at six months. Combination NRT (e.g., patch plus fast-acting form) yields higher abstinence rates than single therapies, though long-term efficacy remains modest at around 6-15% sustained quitting. NRT primarily targets cessation rather than indefinite substitution, as complete abstinence eliminates all nicotine-related risks. Smokeless tobacco products like offer a non-inhaled alternative, with cohort studies showing switchers from cigarettes experience cancer and rates similar to never-smokers and 90-95% lower than continued smokers. use elevates risk modestly but avoids and respiratory diseases entirely, with overall mortality reductions attributed to absent combustion byproducts. In , where snus prevalence is high, male smoking-related mortality declined faster than in other countries, correlating with snus substitution. Electronic cigarettes aerosolize solutions, bypassing and reducing exposure to harmful chemicals by 95% or more relative to cigarette in studies. Randomized trials demonstrate e-cigarettes outperform NRT for , with 18% abstinence at one year versus 10% for patches, alongside of vascular endothelial benefits over traditional . While not risk-free—containing potential irritants like aldehydes at lower levels than cigarettes—exclusive vaping yields lower disease odds for cardiovascular and respiratory outcomes in population data, though some reviews note comparable short-term effects on function. Heated tobacco products (HTPs), such as , heat without burning, producing emissions with fewer and lower levels of toxicants than cigarettes, leading to reduced biomarkers of potential like nicotine equivalents and volatile organics in short-term user studies. Market data from regions with HTP adoption show decreased combustible cigarette use, though dual use persists and long-term disease outcomes remain understudied; HTPs appear less ful than cigarettes but more so than e-cigarettes. bodies acknowledge HTPs' potential for adult smoker switching but caution against youth initiation due to risks. These alternatives align with causal mechanisms of harm—primarily —offering empirical risk reductions for persistent users, though debates persist over regulatory biases favoring abstinence-only approaches despite data favoring substitution for net gains. Complete quitting remains optimal, but harm reduction tools have contributed to declining in permissive jurisdictions.

References

Add your contribution
Related Hubs
User Avatar
No comments yet.